Globe Life Inc.: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 23, 2023 and accepted by EDGAR at Feb 23, 2023, 16:57 ET.
Business
As filed, 22,001 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Globe Life and the Company refer to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and its subsidiaries and affiliates. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company.
Globe Life's website is: www.globelifeinsurance.com (http://www.globelifeinsurance.com). Globe Life makes available free of charge through its website, its annual report on Form 10-K, its quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports as soon as reasonably practicable after they have been electronically filed with or furnished to the Securities and Exchange Commission. Other information included in Globe Life's website is not incorporated into this filing.
The following table presents Globe Life's business by primary marketing distribution method. Additional information concerning industry segments may be found in Management’s Discussion and Analysis and in Note 14—Business Segments within the Notes to the Consolidated Financial Statements.
| Primary Distribution Method | Underwriting Company | Products and Target Markets | Distribution |
|---|---|---|---|
| Direct to Consumer Division | Globe Life And Accident Insurance Company McKinney, Texas | Individual life and supplemental health insurance including juvenile and senior life coverage and Medicare Supplement to lower middle-income to middle-income Americans. | Nationwide distribution through direct to consumer channels: including direct mail, electronic media, and insert media. |
| American Income Life Division | American Income Life Insurance Company Waco, Texas | Individual life and supplemental health insurance marketed to working families. | 9,444 average producing agents in the U.S., Canada, and New Zealand. |
| Liberty National Division | Liberty National Life Insurance Company McKinney, Texas | Life and supplemental health insurance distributed through in-home and worksite channels. | 2,775 average producing agents in the U.S. |
| Family Heritage Division | Family Heritage Life Insurance Company of America Cleveland, Ohio | Supplemental limited-benefit health insurance to lower middle-income to middle-income families. | 1,210 average producing agents in the U.S. |
| United American Division | United American Insurance Company McKinney, Texas | Medicare Supplement coverage to Medicare beneficiaries and, to a lesser extent, supplemental limited-benefit health coverage to people under age 65. | 3,327 independent producing agents in the U.S. |
2
Insurance
Life Insurance
The distribution channels for life insurance products include direct to consumer, exclusive agents, and independent agents. These methods are described in greater detail within the primary marketing distribution channel chart as seen above. The following table presents annualized premium in force for the three years ended December 31, 2022 by distribution method:
| Annualized Premium in Force(1) (Dollar amounts in thousands) 2022 | 2021 | 2020 | |
|---|---|---|---|
| Direct to Consumer | $936,507 | $929,197 | $881,012 |
| Exclusive agents: | |||
| American Income | 1,553,003 | 1,458,408 | 1,325,293 |
| Liberty National | 360,963 | 341,332 | 318,545 |
| Independent agents: | |||
| United American | 7,609 | 8,426 | 9,314 |
| Other | 203,438 | 205,822 | 205,785 |
| $3,061,520 | $2,943,185 | $2,739,949 |
(1) See definition of annualized premium in force under Results of Operations in Management's Discussion & Analysis.
Globe Life's insurance subsidiaries write a variety of nonparticipating ordinary life insurance products. These include traditional whole life, term life, and other life insurance. The Company does not currently sell interest-sensitive whole life products. The following tables present selected information about Globe Life's life insurance products.
| Whole life: | Annualized Premium in Force (Dollar amounts in thousands) 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total |
|---|---|---|---|---|---|---|
| Traditional | $2,106,878 | 69 | $2,011,349 | 68 | $1,857,106 | 68 |
| Interest-sensitive | 31,838 | 1 | 33,912 | 1 | 36,297 | 1 |
| Term | 756,471 | 25 | 750,005 | 26 | 716,698 | 26 |
| Other | 166,333 | 5 | 147,919 | 5 | 129,848 | 5 |
| $3,061,520 | 100 | $2,943,185 | 100 | $2,739,949 | 100 |
| Whole life: | Policy Count and Average Face Amount Per Policy (Dollar amounts in thousands) 2022 Policy Count | Average Face Amount per Policy | 2021 Policy Count | Average Face Amount per Policy | 2020 Policy Count | Average Face Amount per Policy |
|---|---|---|---|---|---|---|
| Traditional | 9,011,227 | $15.7 | 8,963,774 | $15.3 | 8,717,785 | $14.7 |
| Interest-sensitive | 183,887 | 20.4 | 191,536 | 20.4 | 199,975 | 20.3 |
| Term | 4,720,870 | 15.3 | 4,731,044 | 15.3 | 4,526,172 | 15.1 |
| Other | 453,515 | 16.1 | 432,372 | 15.3 | 408,859 | 14.3 |
| 14,369,499 | $15.6 | 14,318,726 | $15.3 | 13,852,791 | $14.9 |
3
Health Insurance
The following table presents Globe Life's health insurance annualized premium in force for the three years ended December 31, 2022 by distribution channel.
| Annualized Premium in Force (Dollar amounts in thousands) 2022 | 2021 | 2020 | |
|---|---|---|---|
| Direct to Consumer | $72,161 | $74,627 | $77,522 |
| Exclusive agents: | |||
| Liberty National | 196,336 | 196,783 | 196,534 |
| American Income | 113,087 | 111,102 | 104,701 |
| Family Heritage | 387,897 | 363,226 | 338,309 |
| Independent agents: | |||
| United American | 558,373 | 540,340 | 476,296 |
| $1,327,854 | $1,286,078 | $1,193,362 |
Globe Life offers Medicare Supplement and limited-benefit supplemental health insurance products that include primarily critical illness and accident plans. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.
The following table presents supplemental health annualized premium in force information for the three years ended December 31, 2022 by product category.
| Annualized Premium in Force (Dollar amounts in thousands) 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| Limited-benefit plans | $735,858 | 55 | $700,767 | 54 | $617,759 | 52 |
| Medicare Supplement | 591,996 | 45 | 585,311 | 46 | 575,603 | 48 |
| $1,327,854 | 100 | $1,286,078 | 100 | $1,193,362 | 100 |
Annuities
Annuity products include single-premium and flexible-premium deferred annuities. Annuities in each of the three years ended December 31, 2022, comprised less than 1% of premium. The Company does not currently market stand-alone fixed or deferred annuity products.
Pricing
Premium rates for life and health insurance products are established using assumptions as to future mortality, morbidity, persistency, investment income, expenses, and target profit margins. These assumptions are based on Company experience and projected investment earnings rates. Revenues for individual life and health insurance products are primarily derived from premium income, and, to a lesser extent, through policy charges to the policyholder account values on annuity products and certain individual life products. Profitability is affected by actual experience deviations from the established assumptions and to the extent investment income varies from that required for policy reserves.
Collections for annuity products and certain life products are not recognized as revenues, but are added to policyholder account values. Revenues from these products are derived from charges to the account balances for insurance risk and administrative costs. Profits are earned to the extent these revenues exceed actual costs. Profits are also earned from investment income in excess of the amounts required for policy reserves.
Underwriting
The underwriting standards of Globe Life's insurance subsidiaries are established by management. Each subsidiary uses information obtained from the application, and in some cases, telephone interviews with applicants, inspection reports, pharmacy data, motor vehicle records, responses to both medical and non-medical questions, doctors’ statements and/or medical examinations. This information is used to determine whether a policy should be issued in accordance with the application, with a different rating, with a rider, with reduced coverage, or rejected.
Reserves
The life insurance policy reserves reflected in Globe Life's consolidated financial statements as future policy benefits are calculated based on accounting principles generally accepted in the United States of America (GAAP). These reserves, with future premiums and the associated interest compounded at assumed rates, must be sufficient to cover policy and contract obligations as they mature. Generally, the mortality and persistency assumptions used in the calculations of reserves are based on Company experience. Similar reserves are held on most of the health insurance policies written by Globe Life's insurance subsidiaries, since these policies generally are issued on a guaranteed-renewable basis. The assumptions used in the calculation of Globe Life's reserves are reported in Note 1—Significant Accounting Policies. Reserves for annuity products and certain life products consist of the policyholders’ account values and are increased by policyholder deposits and interest credited and are decreased by policy charges and benefit payments.
Reinsurance
Globe Life has historically participated in very limited third-party reinsurance as a result of the low face amounts of the policies sold by the Company. See Schedule IV and Note 6—Commitments and Contingencies for more information.
Investments
The nature, quality, and percentage mix of insurance company investments are regulated by state laws. The investments of Globe Life insurance subsidiaries consist predominantly of high-quality, investment-grade securities. Approximately 91% of our invested assets, at fair value, are fixed maturities at December 31, 2022 (see Note 4—Investments and Management’s Discussion and Analysis).
Competition
Globe Life competes with other insurance carriers through policyholder service, price, product design, and sales efforts. While there are insurance companies competing with Globe Life, no individual company dominates any of Globe Life's life or health insurance markets.
Globe Life's health insurance products compete with, in addition to the products of other health insurance carriers, health maintenance organizations, preferred provider organizations, and other health care-related institutions which provide medical benefits based on contractual agreements.
The Company effectively competes with other carriers, in part, due to its ability to operate at lower policy acquisition and administrative expense levels than peer companies. This allows Globe Life to have competitive rates while maintaining higher underwriting margins.
Regulation
***Insurance—***Insurance companies are subject to regulation and supervision in the states in which they do business. The laws of the various states establish agencies with broad administrative and supervisory powers which include, among other things, granting and revoking licenses to transact business, regulating trade practices, licensing agents, approving policy forms, approving certain premium rates, setting minimum reserve and loss ratio requirements, determining the form and content of required financial statements, and prescribing the type and amount of investments permitted. Insurance companies are also required to file detailed annual reports with supervisory agencies, and records of their business are subject to examination at any time. Under the rules of the
National Association of Insurance Commissioners (NAIC), insurance companies are examined periodically by one or more of the supervisory agencies.
***Risk-Based Capital (RBC)—***The NAIC requires that a risk-based capital formula be applied to all life and health insurers. The risk-based capital formula is a threshold formula rather than a target capital formula. It is designed only to identify companies that require regulatory attention and is not to be used to rate or rank companies that are adequately capitalized. All Globe Life's insurance subsidiaries are more than adequately capitalized under the risk-based capital formula. See further discussion of RBC in Capital Resources.
***Holding Company—***States have enacted legislation requiring registration and periodic reporting by insurance companies domiciled within their respective jurisdictions that control or are controlled by other corporations so as to constitute a holding company system. Globe Life Inc. and its subsidiaries have registered as a holding company system pursuant to such legislation in Indiana, Nebraska, Ohio, and New York.
Insurance holding company system statutes and regulations impose various limitations on investments in subsidiaries, and may require prior regulatory approval for material transactions between insurers and affiliates and for the payment of certain dividends and other distributions.
Environmental, Social, and Governance (ESG)
Globe Life’s sustainable business practices are a driver of the success and longevity that our Company has experienced since its origin. We plan to advance our sustainable business practices by further developing the Company's ESG strategy and have aligned disclosures with the Sustainability Accounting Standards Board (SASB) standards and the Task Force on Climate-related Financial Disclosures (TCFD) recommendations.
Environmental responsibility and sustainability are key components of our overall corporate responsibility efforts. We strive to reduce our impact on the environment by implementing green building initiatives at our corporate facilities, placing a company-wide emphasis on recycling and reducing waste generally, and focusing on efforts to reduce the use of paper and water. With respect to social matters, our focus continues to be on supporting a culture that is inclusive and attractive for all of our employees and independent sales agents. We are committed to maintaining a diverse workforce that reflects the communities in which we work. In addition, to enable the Company to appropriately respond to ESG-related challenges and opportunities, the Company has in place an ESG Committee, and the Board and its committees regularly engage with senior management on relevant ESG-related issues.
Human Capital Management
Globe Life's talent base encompasses a broad range of experience that possesses the depth of critical skills to efficiently and effectively accomplish our business purpose and mission, serve our policyholders, and protect our shareholders' interests. Maintaining superior human capital is a key driver to the success and longevity that our Company has experienced since its origins dating back to the early 1900s. As of December 31, 2022, the Company had 3,543 full time, part-time, and temporary employees, a 10% increase over the prior year. The increase in headcount in 2022 was primarily to support the increased growth in recent periods, as well as lower attrition levels than normal. The Company engages over 13,700 independently-contracted insurance agents. Refer to Management's Discussion & Analysis for exclusive agent counts.
People, Culture, and Community
At Globe Life, we are united by our mission to—Make Tomorrow Better1 and this starts with our employees and agents. Beyond providing insurance protection for millions of individuals, serving our policyholders and generating financial results for our shareholders, we focus on cultivating a healthy, positive culture and a thriving community within and among our campuses that is inclusive of and attractive for all. Globe Life promotes a diverse work force, where differences are celebrated and inclusiveness is embraced, to better enable our employees to consistently achieve outstanding individual and collective results. Our commitment to diversity starts at the top; of the 10 independent Board members, 50% are women and 20% are racial/ethnic minorities as of December 31, 2022.
1Per the Globe Life Employee Handbook, the Globe Life mission statement is "We help families Make Tomorrow Better by working to protect their financial future."
As of December 31, 2022 and 2021, the Globe Life employees, (excluding independently-contracted agents) identify as follows:
2022
| Ethnicity/Race | Gender | Generations | |||
|---|---|---|---|---|---|
| White | 54% | Female | 68% | Baby Boomers (1946-1964) | 18% |
| Black or African American | 22 | Male | 32 | Gen X (1965-1977) | 30 |
| Hispanic or Latino | 13 | Millennials (1978-1995) | 43 | ||
| Asian | 9 | Gen Z (1996-2012) | 9 | ||
| American Indian or Alaskan Native | 1 | ||||
| Native Hawaiian or Pacific Islander | — | ||||
| Other or Not Specified | 1 | ||||
| Total | 100% | 100% | 100% |
2021
| Ethnicity/Race | Gender | Generations | |||
|---|---|---|---|---|---|
| White | 56% | Female | 66% | Baby Boomers (1946-1964) | 20% |
| Black or African American | 21 | Male | 34 | Gen X (1965-1977) | 31 |
| Hispanic or Latino | 12 | Millennials (1978-1995) | 41 | ||
| Asian | 9 | Gen Z (1996-2012) | 8 | ||
| American Indian or Alaskan Native | 1 | ||||
| Native Hawaiian or Pacific Islander | — | ||||
| Other or Not Specified | 1 | ||||
| Total | 100% | 100% | 100% |
We conduct a confidential survey biennially to give our employees the opportunity to provide candid feedback about their experiences at the Company, including but not limited to, confidence in the Company and leadership, competitiveness of our compensation and benefit package, and departmental relationships. The results are shared with our employees, reviewed by senior leadership, and used to identify areas for improvement and create action plans based on the employee feedback received.
We strive to Make Tomorrow Better, in part by giving financial and service contributions to programs that provide hands-on assistance in the communities where we live, work, serve, and visit. We focus our charitable giving on organizations that support children, families, veterans, and seniors, as well as those that work to ensure people are able to live full, healthy lives. These categories align with our mission to help families Make Tomorrow Better by working to protect their financial future. In 2022, we provided financial support of approximately $4.0 million to organizations within that focus, including charities that support underserved communities, provide scholarships to youth, and advance equity and diversity efforts.
Talent Development
At Globe Life, we believe investing in our employees through training and development is paramount to their success. We have developed a learning ecosystem that includes a multitude of professional development opportunities, including online, self-directed, and instructor-led courses on a variety of topics. An education assistance program is also offered to facilitate growth in an area related to one's current position with the Company.
Health, Safety, and Wellness
We strive to provide a safe and healthy work environment for every employee. We furnish employees with numerous tools and trainings throughout the year to help ensure they have, at their fingertips, the best information to safely engage with co-workers, customers, and third parties. In furtherance of our commitment to our employees, we offer a comprehensive employee benefits package that includes competitive monetary benefits, retirement benefits through a Section 401(k) plan and a qualified pension to eligible employees, fitness center reimbursement, paid-time-off (based on years of service), health insurance, dental and vision insurance, employee resource program, health savings and flexible spending accounts, family leave, and tuition assistance.
The Company remains committed to the well-being and safety of its employees, agents, customers, guests, vendors and shareholders in our resolve to maintain a stable and secure business environment. In response to the COVID-19 pandemic, our crisis management and incident response teams guided the Company through an expedited, yet smooth, transition towards working remotely. In 2022, the Company continued to implement steps that were effective during the pandemic to ensure the health and safety of our employees, including:
- Continuation of business operations, both in a remote and hybrid work environment;
- Maintaining workplace health and safety protocols to allow employees to safely return to Company facilities on a voluntary basis;
- Enhancements to “Resilient@Globe Life,” an intra-company website dedicated to COVID-19 issues, which provides employees with relevant and timely information, and interactive employee guides;
- Extension of our short-term disability benefits to support employees unable to work as a result of contracting or being exposed to COVID-19; and
- Communication with employees on pandemic-related policies and procedures, implementation of emergency business operations (such as social distancing and enhanced cleaning protocols at company facilities), and provision of pandemic health and wellness resources (including seminars regarding mental health).
Risk factors
As filed, 26,472 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Risks Related to Our Business
The insurance industry is a regulated industry, populated by many public and private companies. We operate in the industry's life and health insurance sectors, each of which has its own set of risks.
Business and Operational Risks
The development and maintenance of our various distribution channels are critical to growth in product sales and profits.
Our future success depends, in substantial part, on our ability to recruit, hire, and motivate highly-skilled insurance personnel. Further, the development and retention of producing agents are critical to supporting sales growth in our agency operations because our insurance sales are primarily made to individuals.
A failure to effectively develop new methods of reaching consumers, realize cost efficiencies or generate an attractive value proposition in our Direct to Consumer Division business could result in reduced sales and profits. In addition, if we do not provide an attractive career opportunity with competitive compensation as well as motivation for producing agents to increase sales of our products, our growth could be impeded. Doing so may be difficult due to many factors, including but not limited to, fluctuations in economic and industry conditions and the effectiveness of our compensation programs and competition among other employers.
Our life insurance products are sold in niche markets. We are at risk should any of these markets diminish.
We have several life distribution channels that focus on distinct market niches, three of which are labor unions, affinity groups, and sales via Direct to Consumer solicitations. Deterioration of our relationships with either organized labor or affinity groups, or adverse changes in the public’s receptivity to Direct to Consumer marketing initiatives could negatively affect our life insurance business.
The impact of COVID-19 and related risks could materially affect our results of operations, financial position and/or liquidity.
The effects of the COVID-19 pandemic, and U.S. and international responses, are wide-ranging, costly, and disruptive, and has resulted in significant disruptions in economic activity and financial markets. Excess deaths from non-COVID causes have directly and indirectly adversely affected the Company and will likely continue to do so for an uncertain period of time.
The COVID-19 pandemic subjects the Company to various potential risks that could adversely affect the Company in different ways, including but not limited to the following:
- Reduced sales resulting from potential limitations in the virtual sales and agent recruiting process or reductions in the willingness or ability of consumers to purchase our products;
- Reduced cash flows from lower premiums, higher surrenders and greater than anticipated claim payments;
- Disruptions, delays, and increased costs and risks related to employees working remotely, having limited or no access to our facilities, and experiencing reductions or interruptions of critical or essential services;
- Ratings downgrades, increased bankruptcies and credit spread widening in industries in which we invest in our investment portfolio.
Actual or alleged misclassification of independent contractors at our insurance subsidiaries could result in adverse legal, tax or financial consequences.
A significant portion of our sales agents are independent contractors. Although we believe we have properly classified such individuals, a risk nevertheless exists that a court, the Internal Revenue Service or other authority will take the position that our sales agents are employees. From time-to-time, we are subject to civil litigation, including class and collective action litigation, alleging that we have improperly classified certain of our sales agents as independent contractors. Though we believe our sales agents are properly classified as independent contractors, a future adverse judgment in connection with such litigation could result in substantial damages.
Financial and Strategic Risks
Our investments are subject to market and credit risks. Significant downgrades, delinquencies and defaults in our investment portfolio could potentially result in lower net investment income and increased realized and unrealized investment losses.
Our invested assets are subject to the customary risks of defaults, downgrades, and changes in market values. Our investment portfolio consists predominately of fixed maturity and short-term investments, where we are exposed to the risk that individual issuers will not have the ability to make required interest or principal payments. A concentration of these investments in any particular issuer, industry, group of related industries or geographic areas could increase this risk. Factors that may affect both market and credit risks include interest rate levels (consisting of both treasury rate and credit spread), financial market performance, disruptions in credit markets, general economic conditions, legislative changes, particular circumstances affecting the businesses or industries of each issuer and other factors beyond our control.
Additionally, as the majority of our investments are long-term fixed maturities that we typically hold until maturity, a significant increase in interest rates and/or credit spreads could cause a material temporary decline in the fair value of our fixed investment portfolio, even with regard to performing assets. These declines could cause a material increase in unrealized losses in our investment portfolio. Significant unrealized losses could substantially reduce our capital position and shareholders’ equity. It is possible our investment in certain of these securities with unrealized losses could experience a credit event where an allowance for credit loss is recorded, reducing net income.
We cannot be assured that any particular issuer, regardless of industry, will be able to make required interest and principal payments on a timely basis or at all. Significant downgrades or defaults of issuers could negatively impact our risk-based capital ratios, leading to potential downgrades of the Company by rating agencies, potential reduction in future dividend capacity from our insurance subsidiaries, and/or higher financing costs at Globe Life Inc. (Parent Company) should additional statutory capital be required.
Changes in interest rates could negatively affect income.
Declines in interest rates expose insurance companies to the risk that they will fail to earn the level of interest on investments assumed in pricing products and in setting discount rates used to calculate net policy liabilities, which could have a negative impact on income. Significant decreases in interest rates could result in calls by issuers of investments, where such features are available to issuers. Any such calls could result in a decline in our investment income, as reinvestment of the proceeds would likely be at lower interest rates.
An increase in interest rates could result in certain policyholders surrendering their life or annuity policies for cash, thereby potentially requiring our insurance subsidiaries to liquidate invested assets if other sources of liquidity are not available to meet their obligations. In such a case, realized losses could result from the sale of the invested assets and could adversely affect our statutory income, required capital levels, and results of operations.
Our ability to fund operations is substantially dependent on available funds from our insurance subsidiaries.
As a holding company with no direct operations, our principal asset is the capital stock of our insurance subsidiaries, which periodically declare and distribute dividends on their capital stock. Moreover, our liquidity, including our ability to pay our operating expenses and to make principal and interest payments on debt securities or other indebtedness owed by us, as well as our ability to pay dividends on our common stock or any preferred stock, depends significantly upon the surplus and earnings of our insurance subsidiaries and the ability of these subsidiaries to pay dividends or to advance or repay funds to us. Other sources of liquidity include a variety of short-term and long-term instruments, including our credit facility, commercial paper, long-term debt, Federal Home Loan Bank (FHLB), intercompany financing and reinsurance.
The principal sources of our insurance subsidiaries’ liquidity are insurance premiums, as well as investment income, maturities, repayments and other cash flow from our investment portfolio. Our insurance subsidiaries are subject to various state statutory and regulatory restrictions applicable to insurance companies that limit the amount of cash dividends, loans, and advances that those subsidiaries may pay to us, including laws establishing minimum solvency and liquidity thresholds. For example, in the states where our companies are domiciled, an insurance company generally may pay dividends only out of its unassigned surplus as reflected in its statutory financial statements filed in that state. Additionally, dividends paid by insurance subsidiaries are restricted based on regulations by their states of domicile. Accordingly, impairments in assets or disruptions in our insurance subsidiaries’ operations that reduce their capital or cash flow could limit or disallow the payment of dividends, a principal source of our cash flow, to us.
Changes in laws or regulations in the states in which our companies are domiciled could constrain the ability of our insurance subsidiaries to pay dividends or to advance or repay funds to us in sufficient amounts and at times necessary to pay our debt obligations, corporate expenses, or dividends on our capital stock.
Adverse capital and credit market conditions may significantly affect our ability to meet liquidity needs or access capital, as well as affect our cost of capital.
Should interest rates increase in the future, the higher interest expense on any newly issued debt may reduce net income. In addition, if the credit and capital markets were to experience significant disruption, uncertainty and instability, these conditions could adversely affect our access to capital. Such market conditions could limit our ability to replace maturing debt obligations in a timely manner or at all and/or access the capital necessary to grow our business.
In the unlikely event that current sources of liquidity do not satisfy our needs, we may have to seek additional financing or raise capital. The availability and cost of additional financing or capital depend on a variety of factors such as market conditions, the general availability of credit or capital, the volume of trading activities, the overall availability of credit to the insurance industry and our credit ratings and credit capacity. Additionally, customers, lenders or investors could develop a negative perception of our financial prospects if we were to incur large investment losses or if the level of our business activity decreased due to a market downturn. Our access to funds may also be impaired if regulatory authorities or rating agencies take negative actions against us. If our internal sources of liquidity prove to be insufficient, we may not be able to successfully obtain additional financing on favorable terms or at all. As such, we may be forced to delay raising capital, issue shorter term securities than we would prefer or bear an unattractive cost of capital which could decrease our profitability and significantly reduce our financial flexibility. If so, our results of operations, financial condition, consolidated RBC, and cash flows could be materially negatively affected.
Industry Risks
Variations in actual-to-expected rates of mortality, morbidity and persistency could materially negatively affect our results of operations and financial condition.
We establish policy reserves to pay future policyholder benefits. These reserves do not represent an exact calculation of liability, but rather are actuarial estimates based on models and accounting requirements that include many assumptions and projections which are inherently uncertain. The reserve computations involve the exercise of significant judgment with respect to levels of mortality, morbidity, persistency, and investment yields, as well as the timing of premium and benefit payments. Even though our actuaries continually test actual-to-expected results, actual results may differ significantly from the levels assumed, which could result in increased policy obligations and expenses and thus negatively affect our profit margins and income.
A ratings downgrade or other negative action by a rating agency could materially affect our business, financial condition, and results of operations.
Various rating agencies review the financial performance and condition of insurers, including our insurance subsidiaries, and publish their financial strength ratings as indicators of an insurer’s ability to fulfill its contractual obligations. These ratings are important to maintaining public confidence in our insurance products. A downgrade or other negative action by a rating agency with respect to the financial strength ratings of our insurance subsidiaries could negatively affect us by limiting or restricting the ability of our insurance subsidiaries to pay dividends to us and reducing our sales by adversely affecting our ability to sell insurance products through independent insurance agencies.
The supplemental health insurance market is subject to substantial regulatory scrutiny.
Regulatory changes could impact our Medicare Supplement and other supplemental health business. The nature and timing of any such changes cannot be predicted and could have a material adverse effect on our supplemental health insurance business.
Obtaining timely and appropriate premium rate increases for certain supplemental health insurance policies is critical.
A significant percentage of the supplemental health insurance premiums that our insurance subsidiaries earn is from Medicare Supplement insurance. Medicare Supplement insurance, including conditions under which the premiums for such policies may be increased, is highly regulated at both the state and federal level. As a result, our Medicare Supplement business is characterized by lower profit margins than life insurance and requires strict administrative discipline and economies of scale for success. Since Medicare Supplement policies are coordinated with the federal Medicare program, which commonly experiences health care inflation every year, annual premium rate increases for the Medicare Supplement policies are typically necessary. Accordingly, the inability of our insurance subsidiaries to obtain approval of appropriate premium rate increases for supplemental health insurance plans in a timely manner from state insurance regulatory authorities could adversely impact their profitability and thus our business, financial condition, and results of operations.
Our business is subject to the risk of the occurrence of catastrophic events that could adversely affect our financial condition or operations.
Our insurance policies are issued to and held by a large number of policyholders throughout the United States in relatively low-face amounts. Accordingly, it is unlikely that a large portion of our policyholder base would be affected by a single natural disaster. However, our insurance operations could be exposed to the risk of catastrophic mortality or morbidity caused by events such as a pandemic, hurricane, earthquake, or man-made catastrophes, including acts of terrorism or war, which may produce significant claims in larger areas, especially those that are heavily populated. Claims resulting from natural or man-made catastrophic events could cause substantial volatility in our financial results for any fiscal quarter or year and could materially reduce our profitability or harm our financial condition.
Our life and health insurance products are particularly exposed to risks of catastrophic mortality, such as a pandemic or other events that result in a large number of deaths. In addition, the occurrence of such an event in a concentrated geographic area could have a severe disruptive effect on our workforce and business operations. The likelihood and severity of such events cannot be predicted and are difficult to estimate. In such an event, the impact to our operations could have a material adverse impact on our ability to conduct business and on our results of operations and financial condition, particularly if those problems affect employees performing operational tasks and supporting computer-based data processing, or destroy the capability to transmit, store, and retrieve valuable data. In addition, in the event that a significant number of our management were unavailable following a disaster, the achievement of our strategic objectives could be negatively impacted.
Our business is subject to the risk of direct or indirect effects of climate change.
Climate change may increase the frequency and severity of weather-related natural disasters and pandemics, which may adversely impact our mortality and morbidity rates and disrupt our business operations. In addition, climate change and climate change regulation may affect the prospects of companies and other entities whose securities we hold, or our willingness to continue to hold their securities. Climate change may also influence investor sentiment with respect to the Company and investments in our portfolio.
Legal, Regulatory, and Compliance Risks
Our businesses are heavily regulated and changes in regulation may reduce our profitability and growth.
Insurance companies, including our insurance subsidiaries, are subject to extensive supervision and regulation in the states in which they conduct business. The primary purpose of this supervision and regulation is the protection of policyholders, not investors. Regulatory agencies have broad administrative power over numerous aspects of our business, including premium rates and other terms and conditions included in the insurance policies offered by our insurance subsidiaries, marketing practices, advertising, agent licensing, policy forms, capital adequacy, solvency, reserves and permitted investments. Also, regulatory authorities have relatively broad discretion to grant, renew or revoke licenses or approvals. The insurance laws, regulations and policies currently affecting our companies may change at any time, possibly having an adverse effect on our business. Should regulatory changes occur, we may be unable to maintain all required licenses and approvals, or fully comply with the wide variety of applicable laws and regulations or the relevant authority’s interpretation of such laws and regulations. If we do not have the requisite licenses and approvals or do not comply with applicable regulatory requirements, the insurance regulatory authorities could preclude or temporarily suspend some or all of our business activities and/or impose substantial fines.
Changes in U.S. federal income tax law could increase our tax costs or negatively impact our insurance subsidiaries' capital.
Changes to the Internal Revenue Code, administrative rulings, or court decisions affecting the insurance industry, including the products insurers offer, could increase our effective tax rate and lower our net income, adversely impact our insurance subsidiaries' capital, or limit the ability of our insurance subsidiaries to sell certain of their products.
Changes in accounting standards issued by accounting standard-setting bodies may affect our financial statements, reduce our reported profitability and change the timing of profit recognition.
Our financial statements are subject to the application of GAAP and accounting practices as promulgated by the National Association of Insurance Commissioners’ statutory accounting practices (NAIC SAP), which principles are periodically revised and/or expanded. Accordingly, from time to time we are required to adopt new or revised accounting standards or guidance issued by recognized authoritative bodies. Future accounting standards that we are required to adopt could change the current accounting treatment that we apply to our consolidated financial statements. These changes, including underlying assumptions, projections, estimates or judgments/interpretations by management, could have a material adverse effect on our business, financial condition, and results of operations. (Refer to Note 1—Significant Accounting Policies under the caption Accounting Pronouncements Yet to be Adopted)
Non-compliance with laws or regulations related to customer and consumer privacy and information security, including a failure to ensure that our business associates with access to sensitive customer and consumer information maintain its confidentiality, could materially adversely affect our reputation and business operations.
The collection, maintenance, use, disclosure and disposal of personally identifiable information by our insurance subsidiaries are regulated at the international, federal, and state levels. Applicable laws and rules are subject to change by legislation or administrative or judicial interpretation. Various state laws address the use and disclosure of personally identifiable information to the extent they are more restrictive than those contained in the privacy and security provisions in the federal Gramm-Leach-Bliley Act of 1999 (GLBA), the Health Information Technology for Economic and Clinical Health Act (HITECH), and in the Health Insurance Portability and Accountability Act of 1996 (HIPAA). HIPAA also requires that we impose privacy and security requirements on our business associates (as that term is defined in the HIPAA regulations). Noncompliance with any privacy laws, whether by us or by one of our business associates, could have a material adverse effect on our business, reputation and results of operations and could result in material fines and penalties, various forms of damages, consent orders regarding our privacy and security practices, adverse actions against our licenses to do business, and injunctive relief.
General Risk Factors
The failure to maintain effective and efficient information systems at the Company could compromise data security, thereby adversely affecting our financial condition and results of operations.
Our business is highly dependent upon the internet, third-party service providers, and information systems to operate in an efficient and resilient manner. We gather and maintain data for the purpose of conducting marketing, actuarial analysis, sales and policy administration functions.
Malicious third-parties, employee or agent errors or disasters affecting our information systems could impair our business operations, regulatory compliance, and financial condition. Employee or agent malfeasance or errors in the handling of our information systems may result in unauthorized access to customer or proprietary information, or an inability to use our information systems to efficiently support business operations.
More frequent and sophisticated cyberattacks and more impactful regulatory oversight models could result in additional costs to protect against security breaches. Any breach of confidential information systems resulting from the above factors could damage our reputation in the marketplace, deter potential customers from purchasing our products, result in the loss of existing customers, subject us to significant civil and criminal liability, constrain cash flows, or require us to incur significant technical, legal, or other expenses.
The failure to effectively maintain and modernize our information technology systems and infrastructure could adversely affect our business.
Our ability to modernize our information technology systems and infrastructure requires us to commit to significant resources, effective planning, and execution. In addition, due to the highly regulated nature of the insurance industry, we must continually implement new, and maintain existing, technology or adapt existing technology to meet compliance requirements of new and proposed regulations. Should we be unable to implement these innovations effectively, efficiently, or in a timely manner, it could result in poor customer experience, poor agent experience, additional expenses, reputational harm, legal and regulatory actions and other adverse consequences. This could also result in the inability to effectively support business operations.
Damage to the brand and reputation of Globe Life or its subsidiaries could affect our ability to conduct business.
Negative publicity through traditional media, internet, social media and other public forums could damage our brand or reputation and adversely impact our agent recruiting efforts, the ability to market our products and the persistency of in-force policies.
We may fail to meet expectations relating to environmental, social, and governance standards and practices.
Certain existing or potential investors, customers and regulators evaluate our business or other practices according to a variety of environmental, social and governance (ESG) standards and expectations. Certain of our regulators have proposed or adopted, or may propose or adopt, ESG rules or standards that would apply to our business. Our practices may be judged by ESG standards that are continually evolving and not always clear. Prevailing ESG standards and expectations may also reflect contrasting or conflicting values or agendas. We may fail to meet our commitments or targets, and our policies and processes to evaluate and manage ESG standards in coordination with other business priorities may not prove completely effective or satisfy investors, customers, regulators, or others. Additionally, we could fail to report accurately or achieve progress on our metrics on a timely basis, or at all, which in-turn could adversely affect our reputation, business, financial performance and growth. We may face adverse regulatory, investor, customer, media, or public scrutiny leading to business, reputational, or legal challenges.
Properties
As filed, 352 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Globe Life Inc., through its subsidiaries, owns or leases buildings that are used in the normal course of business. Globe Life Inc. owns and occupies approximately 480,000 combined square feet in McKinney, Texas (headquarters) and at the Waco, Texas and Oklahoma City, Oklahoma campuses. Additionally, the Company leases other buildings across the U.S.
Management's discussion and analysis
As filed, 111,892 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion should be read in conjunction with Globe Life's Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year. For discussion regarding activity from 2020, please refer to the prior filed Form 10-Ks at www.sec.gov (http://www.sec.gov).
"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.
Results of Operations
How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life, supplemental health, and annuities, and the investment segment that supports the product lines. Segments are aligned based on their common characteristics, comparability of the profit margins, and management techniques used to operate each segment.
Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further segmented by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:
Premium revenue (Policy obligations) (Policy acquisition costs and commissions) Underwriting margin
Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
Net investment income (Required interest on net policy liabilities) (Financing costs) Excess investment income
20
Long-Duration Targeted Improvements. As discussed in further detail within Note 1—Significant Accounting Policies, the Company will adopt ASU 2018-12, Financial Services–Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI), effective on January 1, 2023. The Company has selected the modified retrospective transition method upon adoption as of the transition date (the “Transition Date”) of January 1, 2021. The accounting adoption will have no economic impact on the cash flows of our business nor influence our business model of providing basic protection-oriented products to the underserved and lower middle to middle-income market. In addition, it will not impact our statutory earnings, statutory capital, nor our capital management philosophies.
The adoption will, however, modify the timing of when profits emerge on our insurance policies and result in the restatement of 2021 and 2022 key figures in the 2023 consolidated financial statements. We are anticipating GAAP net income and net operating income to increase significantly under the new standard primarily due to a reduction in deferred acquisition cost (DAC) amortization in the near to intermediate term. Additionally, future policy benefits on our life insurance business for 2021 and 2022, as restated to reflect the new standard, will be adjusted to reflect updated assumptions used to determine the reserves as well as the treatment of adverse claims experience incurred in 2021 and 2022, which gets spread out over future periods from transition, including those relating to COVID-19. This will result in slightly higher future policy benefits, as a percentage of premium, in future years than what would have been expected under existing guidance. Finally, we expect some modest decreases to future policy benefits, as a percentage of premium, in our health business on some of our limited benefit plans under the new standard.
With respect to future policy benefits, we anticipate an increase of between $9.5 billion and $11.0 billion on the Transition Date, which will be reflected in other comprehensive income. This change reflects an unrealized interest rate loss at transition and is a result of several primary factors:
a. Life insurance future policy benefit cash flows tend to be long as death benefits, which are greater than premium amounts, are typically paid to beneficiaries many years after a policy is issued. This results in a generally longer overall liability duration than the overall asset duration.
b. The new methodology requires the use of current discount rates (upper-medium grade) rather than locked-in discount rates, which are determined when a policy is issued. Current discount rates are generally lower than the locked-in discount rates used to determine net income. The required current discount rate is inconsistent with historical practices, the current asset portfolio and current investment strategy.
c. The methodology requires the net premium ratio2 used to determine future policy benefits be based on locked-in rates rather than permitting the redetermination of the net premium ratio using current discount rates. This restricts the level of gross premiums allowed in the calculation, as well as the level of gross premiums available to offset the impact of current discount rates to the extent these rates are realized in future years. Because of this requirement, the change in future policy benefits results in a measure of unrealized gain (loss) due to differences in discount rates only.
For Globe Life, discount rates lower than the locked-in discount rate under LDTI have the effect of increasing the level of reserves carried due to the use of net premiums in the calculation as compared to current GAAP, which in the loss recognition test, uses the total gross premium. Once implemented, future policy benefits will be sensitive to changes in current discount rates for the reasons stated above. To demonstrate this sensitivity to discount rates, to the extent current discount rates were consistent with rates as of December 31, 2022, we estimate future policy benefits as of the Transition Date would have only increased between $1.5 billion and $2.3 billion.
With respect to shareholders’ equity, as of the end of 2020, reported shareholders’ equity on the Consolidated Balance Sheets was $8.8 billion. We anticipate a decrease in the range of $7.5 billion to $8.5 billion, net of tax, as a result of the requirement to use current discount rates to remeasure the future policy benefits and record the offset through accumulated other comprehensive income (AOCI) at adoption.
If we hold all else equal as of the Transition Date but use current discount rates as of December 31, 2022, the after-tax decrease in AOCI due solely to the increase in future policy benefits would have been in the range of $1.2 billion
2 The net premium ratio is the ratio between the present value of benefits and the present value of gross premium.
to $1.8 billion. AOCI would also be impacted by fluctuations in the valuation of the fixed maturity bond portfolio in this situation.
Another item impacting shareholders’ equity relates to increases in the liability for future policy benefits on smaller, older blocks of business with a minimum floor or net premium ratios capped at 100%. For blocks of business that require increases in future policy benefits to minimum levels, or a net premium ratio capped at 100% on the Transition Date, any difference between the future policy benefits calculated using the discount rate immediately before the Transition Date, and the existing carrying value as of the Transition Date is recorded as an adjustment (decrease) to opening retained earnings. At the Transition Date, we expect an immaterial decrease to opening retained earnings related to these items.
As noted above, we expect GAAP net income and net operating income to increase under the new standard due to a significant decrease in the annual amortization of DAC in the near and intermediate term. This is a result of changes to the calculation of amortization rate, including use of only deferred costs through the valuation date. For business with deferrals of renewal commissions, as is the case with our captive agency channels, the expected amortization rate as a percentage of premium will no longer be level, but will increase over the period of time during which commissions are deferred. The decrease in amortization in the near term will primarily impact our life insurance line of business. In total, we expect the increase in net income in 2023, largely due to the decrease in amortization, to fall within a range of $105 million and $115 million, net of tax.
Regarding our measure of excess investment income, we expect a significant decrease in the figure as a result of the updated standard. This is driven by the removal of interest in the computation of DAC. Although non-GAAP measures, the review of underwriting margin and excess investment income will remain an important part of the Company’s measurement of performance.
Inflation Reduction Act. The Inflation Reduction Act (the Act) was enacted on August 16, 2022, and included a new corporate alternative minimum tax (CAMT). The Act and CAMT go into effect for tax years beginning after 2022. The Company is in the process of evaluating the impact the Act will have, if any, on the financial statements.
Current Highlights, comparing year-to-date 2022 with 2021.
- Net income as a return on equity (ROE) for the year ended December 31, 2022 was 12.3% and net operating income as an ROE, excluding net unrealized gains or losses on the fixed maturity portfolio(1) was 13.4%.
- Total premium increased 5% over the prior year. Life premium increased 4% for the period from $2.9 billion in 2021 to $3.0 billion in 2022. Life underwriting margin increased 23% from $624 million in 2021 to $769 million in 2022.
- Net investment income increased 4% over the same period in the prior year.
- Total net sales increased 2% over the same period in the prior year from $706 million in 2021 to $722 million in 2022.
- Book value per share declined 42% below the same period in the prior year from $85.97 to $49.65. Book value per share, excluding net unrealized gains or losses on the fixed maturity portfolio**(1)**, increased 9% over the prior year from $58.50 in 2021 to $64.01 in 2022.
- The Company incurred $49 million of COVID-19 net life claims (net of reserves released upon death) for the year ended December 31, 2022 compared with $140 million during the same period last year.
- For the year ended December 31, 2022, the Company repurchased 3.3 million shares of Globe Life Inc. common stock at a total cost of $335 million for an average share price of $100.90.
The following graphs represent net income and net operating income for the three years ended December 31, 2022.
(1) As shown in the charts above, net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding net unrealized gains or losses on the fixed maturity portfolio, is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of the net unrealized gains or losses, which are primarily attributable to fluctuation in interest rates on the available-for-sale portfolio. The impact of the adjustment to exclude net unrealized gains or losses on fixed maturities, net of tax is $(1.4) billion and $2.8 billion for the year ended December 31, 2022 and 2021, respectively.
Book value per share, excluding net unrealized gains or losses on the fixed maturity portfolio, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of net unrealized gains or losses, which are primarily attributable to fluctuation in interest rates on the available-for-sale portfolio. The impact of the adjustment to exclude net unrealized gains or losses on fixed maturities is $(14.36) and $27.47 for the year ended December 31, 2022 and 2021, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
Summary of Operations. Net income declined 1% to $740 million in 2022, compared with $745 million in 2021. This decrease was primarily related to an increase in realized losses on the fixed maturity portfolio offset by lower COVID-19 life claims. On a diluted per common share basis, net income per common share for 2022 increased from $7.22 to $7.47. Included in net income were after-tax realized losses of $60 million in 2022, compared with realized after-tax gains of $47 million for 2021. Realized gains and losses are presented more fully under the caption Realized Gains and Losses in this report.
Net operating income from operations increased 14% to $806 million in 2022, compared with $707 million in 2021. On a diluted per common share basis, net operating income per common share increased from $6.86 to $8.15, a 19% increase. Net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Net income was also impacted by certain significant and unusual non-operating items in 2021 and 2022. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.
The Company continues to see positive signs in its core operations, including strong sales, favorable persistency, and a strong ROE, excluding net unrealized gains or losses on the fixed maturity portfolio.
COVID-19. For the year ended December 31, 2022, the Company incurred $49 million of COVID-19 net life claims, compared to $140 million in 2021. Per the Centers for Disease Control and Prevention (CDC), there were approximately 243 thousand U.S. COVID-19 deaths in 2022, down from approximately 460 thousand in 2021. The Company’s level of COVID-19 net life claims, on average for the year, was approximately $2 million per 10,000 U.S. deaths, a decrease from $3 million per 10,000 U.S. deaths in 2021.
Going forward, we anticipate approximately $45 million in impact from excess life claims in 2023 from both COVID-19 and related non-COVID-19 causes at the mid-point of our guidance. We define excess life claims as the additional claims that arose over what would have been expected based on pre-COVID experience. The projected life claims are dependent on many variables, including, but not limited to, projected U.S. deaths from COVID-19, the timing and availability of effective treatments for the disease, vaccination rates and effectiveness of vaccines, impact from potential variants, and the ages and geographic areas in which infections and deaths occur.
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.
Analysis of Profitability by Segment
(Dollar amounts in thousands)
| 2022 | 2021 | 2020 | 2022 Change% | 2021 Change% | |||
|---|---|---|---|---|---|---|---|
| Life insurance underwriting margin | $768,546 | $623,675 | $674,946 | $144,871 | 23 | $(51,271) | (8) |
| Health insurance underwriting margin | 320,712 | 304,302 | 272,369 | 16,410 | 5 | 31,933 | 12 |
| Annuity underwriting margin | 8,226 | 8,704 | 9,029 | (478) | (5) | (325) | (4) |
| Excess investment income | 238,083 | 238,528 | 244,424 | (445) | — | (5,896) | (2) |
| Other insurance: | |||||||
| Other income | 1,246 | 1,216 | 1,325 | 30 | 2 | (109) | (8) |
| Administrative expense | (299,341) | (271,631) | (250,947) | (27,710) | 10 | (20,684) | 8 |
| Corporate and other | (46,806) | (39,825) | (45,783) | (6,981) | 18 | 5,958 | (13) |
| Pre-tax total | 990,666 | 864,969 | 905,363 | 125,697 | 15 | (40,394) | (4) |
| Applicable taxes | (184,321) | (157,472) | (167,771) | (26,849) | 17 | 10,299 | (6) |
| Net operating income | 806,345 | 707,497 | 737,592 | 98,848 | 14 | (30,095) | (4) |
| Reconciling items, net of tax: | |||||||
| Realized gain (loss)—investments | (60,473) | 54,220 | (1,915) | (114,693) | 56,135 | ||
| Realized loss—redemption of debt | — | (7,358) | (501) | 7,358 | (6,857) | ||
| Administrative settlements | — | (1,047) | — | 1,047 | (1,047) | ||
| Non-operating expenses | (4,196) | (1,923) | (816) | (2,273) | (1,107) | ||
| Legal proceedings | (1,972) | (6,430) | (2,587) | 4,458 | (3,843) | ||
| Net income | $739,704 | $744,959 | $731,773 | $(5,255) | (1) | $13,186 | 2 |
The life insurance segment is our primary segment and is the largest contributor to earnings in each year presented. The life insurance segment underwriting margin increased $145 million compared with the prior year, primarily due to lower life claims related to COVID-19 and growth in premiums. The health segment contributed to growth in income in both years, contributing $16 million of additional underwriting margin in 2022 and $32 million in 2021, a result of sustained premium growth.
In 2022, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division. The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the year ended December 31, 2022.
Total premium income rose 5% for the year ended December 31, 2022 to $4.3 billion. Total net sales increased 2% to $722 million, when compared with 2021. Total first-year collected premium (defined in the following section) was $577 million for 2022, compared with $583 million for 2021.
Life insurance premium income increased 4% to $3.0 billion over the prior-year total of $2.9 billion. Life net sales rose 2% to $531 million for the year ended 2022. First-year collected life premium declined 3% to $410 million. Life underwriting margins, as a percent of premium, increased to 25% in 2022 from 22%. Underwriting margin increased to $769 million in 2022, 23% over the same period in 2021, largely a result of a significant decline in COVID-19 net life claims and an increase in premium growth.
Health insurance premium income increased 6% to $1.3 billion over the prior-year total of $1.2 billion. Health net sales rose 4% to $191 million for the year ended 2022. First-year collected health premium rose 5% to $168 million. Health underwriting margins, as a percent of premium, were 25% in 2022 and 2021. Health underwriting margin increased to $321 million for the year ended 2022, 5% over the same period in 2021.
Excess investment income, the measure of profitability of our investment segment, declined slightly during 2022 to $238.1 million from $238.5 million in the same period in 2021. Excess investment income per common share, reflecting the impact of our share repurchase program, increased 4% to $2.41 from $2.31 when compared with the same period in 2021.
Insurance administrative expenses increased 10% in 2022 when compared with the prior-year period. These expenses were 7.0% as a percent of premium during 2022 compared with 6.6% a year earlier.
For the year ended December 31, 2022, the Company repurchased 3.3 million Globe Life Inc. shares at a total cost of $335 million for an average share price of $100.90.
The discussions of our segments are presented in the manner we view our operations, as described in Note 14—Business Segments.
We use three statistical measures as indicators of premium growth and sales over the near term: “annualized premium in force,” “net sales,” and “first-year collected premium.”
- Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the twelve-month period.
- Net sales, a statistical performance measure, is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.
- First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future.
See further discussion of the distribution channels below for Life and Health.
LIFE INSURANCE
Life insurance is the Company's predominant segment. During 2022, life premium represented 70% of total premium and life underwriting margin represented 70% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of excess investment income attributable to the investment segment.
The following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.
Life Insurance
Summary of Results
(Dollar amounts in thousands)
| 2022 Amount | % of Premium | 2021 Amount | % of Premium | 2020 Amount | % of Premium | |
|---|---|---|---|---|---|---|
| Premium and policy charges | $3,023,296 | 100 | $2,898,210 | 100 | $2,672,804 | 100 |
| Policy obligations | 2,045,730 | 68 | 2,070,485 | 71 | 1,809,373 | 68 |
| Required interest on reserves | (771,914) | (26) | (735,282) | (25) | (698,112) | (26) |
| Net policy obligations | 1,273,816 | 42 | 1,335,203 | 46 | 1,111,261 | 42 |
| Commissions, premium taxes, and non-deferred acquisition expenses | 256,546 | 9 | 234,033 | 8 | 212,859 | 8 |
| Amortization of acquisition costs | 724,388 | 24 | 705,299 | 24 | 673,738 | 25 |
| Total expense | 2,254,750 | 75 | 2,274,535 | 78 | 1,997,858 | 75 |
| Insurance underwriting margin | $768,546 | 25 | $623,675 | 22 | $674,946 | 25 |
The higher life insurance underwriting margins, as well as the higher underwriting margins as a percentage of premium, for the year ended December 31, 2022 are primarily a result of growth in premiums along with a decrease in net policy obligations. Net policy obligations amounted to 42% of premiums for the year ended December 31, 2022, compared to 46% in the year-ago period, due to approximately $49 million in COVID-19 net life claims incurred during the year as compared to $140 million in 2021.
Life insurance products are marketed through several distribution channels. Premium income by distribution channel for each of the last three years is as follows:
Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| American Income | $1,505,425 | 50 | $1,402,878 | 48 | $1,257,726 | 47 |
| Direct to Consumer | 981,517 | 32 | 971,461 | 34 | 906,959 | 34 |
| Liberty National | 326,642 | 11 | 311,081 | 11 | 293,897 | 11 |
| Other | 209,712 | 7 | 212,790 | 7 | 214,222 | 8 |
| Total | $3,023,296 | 100 | $2,898,210 | 100 | $2,672,804 | 100 |
Annualized life premium in force was $3.1 billion at December 31, 2022, an increase of 4% over $2.9 billion a year earlier.
The following table shows net sales information for each of the last three years by distribution channel.
Life Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| American Income | $316,715 | 59 | $290,512 | 56 | $253,276 | 52 |
| Direct to Consumer | 125,979 | 24 | 148,846 | 28 | 165,426 | 34 |
| Liberty National | 78,390 | 15 | 71,184 | 14 | 54,931 | 12 |
| Other | 9,844 | 2 | 11,055 | 2 | 10,371 | 2 |
| Total | $530,928 | 100 | $521,597 | 100 | $484,004 | 100 |
The table below discloses first-year collected life premium by distribution channel.
Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| American Income | $257,584 | 63 | $250,937 | 59 | $214,566 | 58 |
| Direct to Consumer | 86,854 | 21 | 111,761 | 27 | 104,262 | 28 |
| Liberty National | 56,085 | 14 | 50,336 | 12 | 42,435 | 11 |
| Other | 8,988 | 2 | 9,705 | 2 | 10,190 | 3 |
| Total | $409,511 | 100 | $422,739 | 100 | $371,453 | 100 |
29
A discussion of life operations by distribution channel follows.
The American Income Life Division markets to members of labor unions and continues to diversify its lead sources by building relationships with other affinity groups, utilizing third-party internet vendor leads and obtaining referrals to facilitate sustainable growth. This division is Globe Life's largest contributor of life premium of any distribution channel at 50% of the Company's 2022 total life premium. Net sales increased 9% to $317 million in 2022 over the 2021 total of $291 million. The increase in life net sales is due to increased productivity plus an improvement in issue rates as some challenges in underwriting, such as staffing and speed to obtain medical records and other information resolved, during the year. The underwriting margin, as a percent of premium, was 33% for the year ended December 31, 2022, up from 30% in the prior year.
This division incurred $16 million in COVID-19 net life claims, representing approximately 1% of premium, for the year ended December 31, 2022, compared with $36 million in COVID-19 net life claims during the prior year.
Below is the average producing agent count at the end of the period for the American Income Life Division. The average producing agent count is based on the actual count at the end of each week during the year. Despite the division's ability to recruit both virtually and in-person, retention challenges still exist. Sales growth in this division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.
| 2022 | 2021 | 2020 | 2022 Change% | 2021 Change% | |||
|---|---|---|---|---|---|---|---|
| American Income | 9,444 | 9,971 | 8,738 | (527) | (5) | 1,233 | 14 |
American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency office openings. In addition to offering financial incentives and training opportunities, the agency has made considerable investments in information technology, including launching a customer relationship management (CRM) tool for the agency force. This tool is designed to drive productivity in lead distribution, conservation of business, manager dashboards and new agent recruiting. Additionally, this division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training, and sales activity. Over the course of the pandemic, the agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of sustainability for our agency force.
The Direct to Consumer Division (DTC) offers adult and juvenile life insurance through a variety of marketing approaches, including direct mailings, insert media, and electronic media. In recent years, production from electronic media, which is comprised of sales through both the internet and inbound phone calls to our call center, has grown faster than direct mail response as customer demand increased marketing activity to internet and mobile technology. The proportion of sales from the internet and inbound phone calls had been steadily increasing prior to COVID-19, but accelerated after the start of the pandemic. The different approaches support and complement one another in the division's efforts to reach the consumer. The DTC's long-term growth has been fueled by constant innovation and name recognition. We continually introduce new initiatives in this division in an attempt to increase response rates.
While the juvenile market is an important source of sales, it is also a vehicle to reach the parents and grandparents of juvenile policyholders, who are more likely to respond favorably to a DTC solicitation for life coverage on themselves in comparison to the general adult population. Also, future offerings to juvenile policyholders and their parents are sources of low acquisition-cost life insurance sales in the future.
DTC net sales decreased 15% to $126 million for the year ended December 31, 2022 compared with $149 million in the prior year. After experiencing higher than normal life net sales in the prior year, sales in the current year are returning to pre-pandemic levels. The decline is also due in part to the impact of recent record inflation on the cost of our direct mailings and on our customers, who generally have less discretionary income to purchase and retain life insurance. DTC incurred $24 million of COVID-19 net life claims, representing approximately 2% of premium, in 2022 compared with $69 million in 2021. DTC’s underwriting margin, as a percent of premium, was 12% for the year ended December 31, 2022 and 7% for the same period in 2021, reflecting the lessening impact of COVID-19 on the division's underwriting results.
The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the agency are expected to help continue this growth. The underwriting margin as a percent of premium was 22%, up from 17% for the year ended 2021. The increase is primarily attributable to lower net policy obligations in relation to premium during the year compared with the same period a year ago. This division incurred $7 million of COVID-19 net life claims, representing approximately 2% of premium, for the year ended December 31, 2022 compared with $28 million in 2021. Net sales increased 10% in 2022 over 2021.
Below is the average producing agent count at the end of the period for Liberty National Division.
| 2022 | 2021 | 2020 | 2022 Change% | 2021 Change% | |||
|---|---|---|---|---|---|---|---|
| Liberty National | 2,775 | 2,716 | 2,575 | 59 | 2 | 141 | 5 |
The Liberty National Division average producing agent count was up slightly compared with the prior year. We continue to execute our long-term plan to grow this agency through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers. Continued expansion of this agency’s presence into more heavily populated, less-penetrated areas will help create long-term agency growth. Additionally, the agency continues to help improve the ability of agents to develop new marketing opportunities. Systems that have been put in place, including the addition of a CRM platform and enhanced analytical capabilities, have also helped the agents develop additional marketing opportunities as well as improve the productivity of agents selling in the individual life market. As the division continues to gain momentum in its sales and recruiting initiatives and advances its technology and CRM platform, the agency anticipates an increase in recruiting of new agents and an increase in the average producing agent count.
The Other Agencies distribution channels primarily include non-exclusive independent agencies selling predominantly life insurance. The Other Agencies contributed $210 million of life premium income, or 7% of Globe Life's total in 2022, but contributed only 2% of net sales for the year.
HEALTH INSURANCE
Health insurance sold by the Company primarily includes Medicare Supplement insurance, accident coverage, and other limited-benefit supplemental health products including cancer, critical illness, heart, and intensive care coverage.
Health premium accounted for 30% of our total premium in 2022, while the health underwriting margin accounted for 29% of total underwriting margin. Health underwriting margin increased 5% to $321 million primarily due to higher premium growth. The Company continues to emphasize life insurance sales relative to health due to life’s superior long-term profitability and its greater contribution to excess investment income.
The following table presents underwriting margin data for health insurance.
Health Insurance
Summary of Results
(Dollar amounts in thousands)
| 2022 Amount | % of Premium | 2021 Amount | % of Premium | 2020 Amount | % of Premium | |
|---|---|---|---|---|---|---|
| Premium | $1,279,412 | 100 | $1,201,676 | 100 | $1,141,097 | 100 |
| Policy obligations | 791,809 | 62 | 758,745 | 63 | 733,481 | 64 |
| Required interest on reserves | (109,789) | (9) | (102,574) | (8) | (93,475) | (8) |
| Net policy obligations | 682,020 | 53 | 656,171 | 55 | 640,006 | 56 |
| Commissions, premium taxes, and non-deferred acquisition expenses | 117,815 | 9 | 97,453 | 8 | 91,959 | 8 |
| Amortization of acquisition costs | 158,865 | 13 | 143,750 | 12 | 136,763 | 12 |
| Total expense | 958,700 | 75 | 897,374 | 75 | 868,728 | 76 |
| Insurance underwriting margin | $320,712 | 25 | $304,302 | 25 | $272,369 | 24 |
Health premium increased 6% from $1.20 billion in 2021 to $1.28 billion in 2022. Health underwriting margin increased 5% from $304 million in 2021 to $321 million in 2022 primarily due to growth in premiums. Further discussion is included below by distribution channel.
Globe Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel for each of the last three years.
Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| United American | $538,428 | 42 | $481,614 | 40 | $452,980 | 40 |
| Family Heritage | 366,820 | 29 | 343,839 | 29 | 317,021 | 28 |
| Liberty National | 185,761 | 14 | 187,327 | 16 | 188,835 | 16 |
| American Income | 117,308 | 9 | 114,950 | 9 | 105,734 | 9 |
| Direct to Consumer | 71,095 | 6 | 73,946 | 6 | 76,527 | 7 |
| Total | $1,279,412 | 100 | $1,201,676 | 100 | $1,141,097 | 100 |
Of total health premium of $1.3 billion, premium from limited-benefit plans comprise $701 million, or 55% of the total, for 2022 compared with $639 million in the prior year. Premium from Medicare Supplement products comprises the remaining 45% or $578 million for 2022 compared with $563 million in 2021.
Annualized health premium in force was $1.33 billion at December 31, 2022, an increase of 3% over the prior year balance of $1.29 billion.
Presented below is a table of health net sales by distribution channel for the last three years.
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| United American | $58,601 | 31 | $63,551 | 35 | $61,690 | 35 |
| Family Heritage | 82,529 | 43 | 72,600 | 39 | 70,665 | 40 |
| Liberty National | 28,916 | 15 | 26,512 | 14 | 22,905 | 13 |
| American Income | 17,555 | 9 | 18,230 | 10 | 18,817 | 10 |
| Direct to Consumer | 3,825 | 2 | 3,465 | 2 | 3,594 | 2 |
| Total | $191,426 | 100 | $184,358 | 100 | $177,671 | 100 |
Of total net sales of $191 million, sales of limited-benefit plans comprise $137 million, or 71% of the total, for 2022 compared with $118 million in 2021. Medicare Supplement sales make up the remaining 29%, or $54 million for 2022 compared with $66 million in 2021.
The following table discloses first-year collected health premium by distribution channel.
Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
| 2022 Amount | % of Total | 2021 Amount | % of Total | 2020 Amount | % of Total | |
|---|---|---|---|---|---|---|
| United American | $64,410 | 39 | $60,386 | 37 | $79,628 | 45 |
| Family Heritage | 60,699 | 36 | 57,427 | 36 | 54,242 | 31 |
| Liberty National | 22,415 | 13 | 20,348 | 13 | 20,169 | 11 |
| American Income | 17,294 | 10 | 18,939 | 12 | 18,536 | 11 |
| Direct to Consumer | 3,115 | 2 | 3,253 | 2 | 3,051 | 2 |
| Total | $167,933 | 100 | $160,353 | 100 | $175,626 | 100 |
First-year collected premium related to limited-benefit plans comprise $108 million, or 64% of total first-year collected premium for 2022 compared with $99 million in 2021. First-year collected premium from Medicare Supplement policies make up the remaining 36%, or $60 million for 2022 compared with $61 million in 2021.
A discussion of health operations by distribution channel follows.
The United American Independent Agency consists of non-exclusive independent agencies who may also sell for other companies. The United American Independent Agency was Globe Life's largest health agency in terms of health premium income.
This division is also Globe Life's largest producer of Medicare Supplement insurance, responsible for 83% of the Company's Medicare Supplement premium and 93% of Medicare Supplement net sales. Medicare Supplement premium in this agency rose 5% to $482 million in 2022 over the prior period premium of $460 million. Medicare Supplement net sales declined 19% to $51 million in 2022 from the prior year. The Medicare Supplement market is highly competitive and thus sales will fluctuate over the years. Underwriting margin as a percent of premium was flat at 15% for 2022 compared with 2021.
The Family Heritage Division primarily markets limited-benefit supplemental health insurance in non-urban areas. Most of its policies include a cash-back feature, such as a return of premium, where any excess of premiums over claims paid is returned to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium in 2022 was 27%, the same as in 2021.
The division experienced a 14% increase in health net sales in 2022 as compared with the 2021, primarily due to an increase in recruiting, agent productivity and training. The division will continue to implement incentive programs to help drive an increase in productivity and the number of producing agents.
Below is the average producing agent count at the end of the indicated periods for the Family Heritage Division. While the agency was relatively flat in agent count as compared with 2021, we anticipate that as COVID-19 and the job market stabilize, agent recruitment opportunities will continue to trend upward.
| 2022 | 2021 | 2020 | 2022 Change% | 2021 Change% | |||
|---|---|---|---|---|---|---|---|
| Average producing agents | 1,210 | 1,213 | 1,325 | (3) | — | (112) | (8) |
The Liberty National Division represented 14% of all Globe Life health premium income at $186 million in 2022. Liberty National markets limited-benefit supplemental health products consisting primarily of critical illness insurance. Much of Liberty National’s health business is generated through worksite marketing targeting small businesses. In 2022, health premium income declined 1%. Liberty National's first-year collected premium increased 10% to $22 million in 2022 compared with $20 million in 2021. Health net sales for 2022 increased by $2 million or 9% from 2021. We anticipate an increase in health net sales going forward at this division as the Company becomes more able to interact face-to-face with customers.
Other distribution. While some of the Company's other distribution channels market health products, selling life insurance is the main emphasis. On a combined basis, they accounted for 15% of health premium in 2022 and 15% in 2021. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division markets primarily Medicare Supplements to employer or union-sponsored groups, adding $4 million of Medicare Supplement net sales in 2022 and $3 million in 2021.
ANNUITIES
Our fixed annuity balances at the end of 2022 and 2021 were $953.3 million and $1.0 billion, respectively. Underwriting margin was $8.2 million for 2022 and $8.7 million for 2021.
We do not currently market stand-alone fixed or deferred annuity products, favoring instead protection-oriented life and supplemental health insurance products. Therefore, we do not expect that annuities will be a significant portion of our business or marketing strategy going forward.
INVESTMENTS
We manage our capital resources including investments, debt, and cash flow through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 14—Business Segments. It is defined as net investment income less both the required interest on net insurance policy liabilities and the interest cost associated with capital funding or “financing costs.”
Management also views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company. Since implementing our share repurchase program in 1986, we have used $9.0 billion of excess cash flow at the Parent Company to repurchase Globe Life Inc. common shares after determining that the repurchases provided a greater risk adjusted after-tax return than other investment alternatives. If we had not used this excess cash to repurchase shares, but had instead invested it in interest-bearing assets, we would have earned more investment income and had more shares outstanding. As excess investment income per diluted common share incorporates all capital resources, we view excess investment income per diluted common share as a useful measure to evaluate the investment segment.
Excess Investment Income. The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.
Analysis of Excess Investment Income
(Dollar amounts in thousands except per share data)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Net investment income | $987,499 | $952,447 | $927,062 |
| Interest on net insurance policy liabilities: | |||
| Required interest on reserves(1) | (919,864) | (877,822) | (833,000) |
| Required interest on deferred acquisition costs | 260,843 | 247,389 | 237,066 |
| Net required interest | (659,021) | (630,433) | (595,934) |
| Financing costs | (90,395) | (83,486) | (86,704) |
| Excess investment income | $238,083 | $238,528 | $244,424 |
| Excess investment income per diluted common share | $2.41 | $2.31 | $2.28 |
| Mean invested assets (at amortized cost) | $19,714,027 | $18,939,317 | $17,987,502 |
| Average net insurance policy liabilities(2) | 11,377,104 | 10,954,500 | 10,460,539 |
| Average debt and preferred securities (at amortized cost) | 2,127,305 | 2,053,935 | 1,859,298 |
(1) Includes $71 thousand of required interest on Federal Home Loan Bank (FHLB) funding agreements in 2022.
(2) Net of deferred acquisition costs, excluding the associated unrealized gains and losses thereon.
Excess investment income declined slightly in 2022 when compared with 2021. Excess investment income per diluted common share increased 4% during 2022 when compared with 2021. Excess investment income per diluted common share generally increases at a faster pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.
Net investment income increased at a compound annual growth rate of 3% over the 3 years ending 2022 while mean invested assets increased at a compound rate of 5% during the same period. The tax equivalent effective annual yield rate earned on the fixed maturity portfolio was 5.16% in 2022. Generally, investment income grows at a slower rate than the assets when the yield on new investments is lower than the yield on dispositions or the average portfolio yield. It also increases at a faster rate than the assets when new investment yields exceed the yield on dispositions or the average portfolio yield. We currently expect that the average annual turnover rate of fixed maturity assets will be less than 2% over the next five years and will not have a material negative impact on net investment income. In addition to fixed maturities, the Company has also invested in limited partnerships with debt like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the investment funds for the year ended December 31, 2022 was 5.65%. See additional information in Note 4—Investments. The following chart presents the growth in net investment income and the growth in mean invested assets.
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Growth in net investment income | 3.7% | 2.7% | 1.8% |
| Growth in mean invested assets (at amortized cost) | 4.1% | 5.3% | 5.6% |
Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss on the fixed maturities portfolio as of December 31, 2022, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.
Required interest on net insurance policy liabilities reduces net investment income, as it is the amount of net investment income considered by management necessary to “fund” required interest on net insurance policy liabilities, which is the net of the benefit reserve liability and the deferred acquisition cost asset. As such, it is removed from the investment segment and applied to the insurance segments to offset the effect of the required interest from the insurance segments. As discussed in Note 14—Business Segments, management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the actuarial interest assumptions used in discounting the benefit reserve liability and the amortization of deferred acquisition costs for our insurance policies in force.
The great majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandate that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business. Each calendar year, we set the discount rate to be used to calculate the benefit reserve liability and the amortization of the deferred acquisition cost asset for all insurance policies issued that year. That rate is based on the new money yields that we expect to earn on cash flow received in the future from policies of that issue year and cannot be changed. The discount rate used for policies issued in the current year has no impact on the in force policies issued in prior years as the rates of all prior issue years are also locked in. As such, the overall discount rate for the entire in force block of 5.8% is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves and the deferred acquisition cost asset by issue year on the entire block of in force business. Business issued in the current year has little impact on the overall weighted-average discount rate due to the size of our in force business. In 2023, new guidance will become effective that will significantly impact the accounting for our long duration contracts including the determination of required interest. Please see Note 1—Significant Accounting Policies for additional information.
Since actuarial discount rates are locked in for life on essentially all of our business, benefit reserves and deferred acquisition costs are not affected by interest rate fluctuations unless a loss recognition event occurs. Due to the strength and consistency of our underwriting margins, we do not expect an extended low interest rate environment will cause a loss recognition event.
Information about interest on net policy liabilities is shown in the following table.
Required Interest on Net Insurance Policy Liabilities
(Dollar amounts in thousands)
| 2022 | Required Interest | Average Net Insurance Policy Liabilities | Average Discount Rate |
|---|---|---|---|
| Life and Health | $614,361 | $10,373,972 | 5.9% |
| Annuity | 44,589 | 1,000,440 | 4.5 |
| FHLB Funding Agreement | 71 | 2,692 | 2.6 |
| Total | $659,021 | $11,377,104 | 5.8 |
| Increase in 2022 | 4.5% | 3.9% | |
| 2021 | |||
| Life and Health | $583,996 | $9,912,914 | 5.9% |
| Annuity | 46,437 | 1,041,586 | 4.5 |
| Total | $630,433 | $10,954,500 | 5.8 |
| Increase in 2021 | 5.8% | 4.7% | |
| 2020 | |||
| Life and Health | $548,066 | $9,391,680 | 5.8% |
| Annuity | 47,868 | 1,068,859 | 4.5 |
| Total | $595,934 | $10,460,539 | 5.7 |
| Increase in 2020 | 4.8% | 3.9% |
37
Financing costs for the investment segment consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Consolidated Statements of Operations.
Analysis of Financing Costs
(Dollar amounts in thousands)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Interest on funded debt | $80,481 | $78,183 | $73,157 |
| Interest on term loan | — | — | 4,193 |
| Interest on short-term debt | 9,875 | 5,270 | 9,302 |
| Other | 39 | 33 | 52 |
| Financing costs | $90,395 | $83,486 | $86,704 |
In 2022, financing costs increased 8% compared with prior year primarily due to rates on the short-term debt. In addition, interest on funded debt was higher in 2022 than the prior year as a result of the 4.80% Senior Notes issued in May 2022, prior the repayment of the 3.80% Senior Notes on September 15, 2022. More information on our debt transactions is disclosed in the Financial Condition section of this report and in Note 11—Debt.
Realized Gains and Losses. Our life and health insurance companies collect premium income from policyholders for the eventual payment of policyholder benefits, sometimes paid many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support the liabilities. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.
Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. In a bond exchange offer, bondholders may consent to exchange their existing bonds for another class of debt securities. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Consolidated Statements of Operations.
Realized gains and losses can be significant in relation to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.
The following table summarizes our tax-effected realized gains (losses) by component for each of the three years ended December 31, 2022.
Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands, except for per share data)
| Fixed maturities: | Year Ended December 31, 2022 Amount | Per Share | 2021 Amount | Per Share | 2020 Amount | Per Share |
|---|---|---|---|---|---|---|
| Sales | $(44,792) | $(0.45) | $(8,100) | $(0.08) | $(28,844) | $(0.27) |
| Matured or other redemptions(1) | 19,076 | 0.19 | 35,684 | 0.34 | 11,712 | 0.11 |
| Provision for credit losses | 306 | — | 2,337 | 0.02 | (2,643) | (0.03) |
| Fair value option—change in fair value | (23,189) | (0.23) | 18,105 | 0.18 | 826 | 0.01 |
| Other(2) | (11,874) | (0.12) | 6,194 | 0.06 | 17,034 | 0.16 |
| Total Realized investment gains (losses)—investments | (60,473) | (0.61) | 54,220 | 0.52 | (1,915) | (0.02) |
| Loss on redemption of debt | — | — | (7,358) | (0.07) | (501) | — |
| Total realized gains (losses) | $(60,473) | $(0.61) | $46,862 | $0.45 | $(2,416) | $(0.02) |
(1) During the three years ended December 31, 2022, 2021, and 2020, the Company recorded $147.6 million, $109.2 million, and $219.8 million of exchanges of fixed maturity securities (noncash transactions) that resulted in $1.5 million, $19.9 million, and $6.2 million, respectively, in realized gains (losses), net of tax.
(2) Other realized gains (losses) are primarily a result of changes in the fair value of exchange traded funds.
As investment yields increased in 2022, the Company disposed of certain fixed maturity investments to improve the risk-adjusted, capital-adjusted returns on the portfolio. While we realized losses, we were able to enhance the yield, credit quality and diversification of the portfolio.
Investment Acquisitions. Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer maturities because they more closely match the long-term nature of our policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.
The following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.
Fixed Maturity Acquisitions Selected Information
(Dollar amounts in thousands)
| Cost of acquisitions(1): | Year Ended December 31, 2022 | 2021 | 2020 |
|---|---|---|---|
| Investment-grade corporate securities | $812,697 | $566,400 | $686,844 |
| Investment-grade municipal securities | 599,946 | 434,482 | 543,088 |
| Other investment-grade securities | 7,577 | 10,465 | 34,171 |
| Total fixed maturity acquisitions | $1,420,220 | $1,011,347 | $1,264,103 |
| Effective annual yield (one year compounded)(2) | 5.18% | 3.39% | 3.73% |
| Average life (in years to next call) | 13.5 | 21.7 | 15.8 |
| Average life (in years to maturity) | 22.8 | 31.7 | 26.3 |
| Average rating | A | A+ | A |
(1) Fixed maturity acquisitions included unsettled trades of $0 in 2022, $7 million in 2021 and $2 million in 2020.
(2) Tax-equivalent basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls," however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.
During 2021 and 2022, acquisitions consisted of securities spanning a diversified range of issuers, industry sectors, and geographical regions. All of the acquired securities were investment grade. In addition to the fixed maturity acquisitions, Globe Life invested $290 million in other long-term investments in 2022 and $258 million in 2021. These investments include primarily investment funds. See Note—4 Investments for further discussion.
New cash flow available for investment has been primarily provided through our insurance operations, cash received on existing investments, and proceeds from dispositions. While dispositions increase funds available for investment, as noted earlier in this discussion, they can also have a negative impact on investment income if the proceeds from the dispositions are reinvested at lower yields than the bonds that were disposed. Dispositions were $852 million in 2022 and $428 million in 2021.
Since fixed maturities represent such a significant portion of our investment portfolio, the remainder of the discussion of portfolio composition will focus on fixed maturities. See a breakdown of the Company's other investments in Other Investment Information within Note 4—Investments.
Selected information concerning the fixed maturity portfolio is as follows:
Fixed Maturity Portfolio Selected Information
| At December 31, 2022 | 2021 | |
|---|---|---|
| Average annual effective yield(1) | 5.19% | 5.17% |
| Average life, in years, to: | ||
| Next call(2) | 14.7 | 15.7 |
| Maturity(2) | 18.5 | 19.0 |
| Effective duration to: | ||
| Next call(2,3) | 8.8 | 10.6 |
| Maturity(2,3) | 10.4 | 12.2 |
(1) Tax-equivalent basis. The yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
(2) Globe Life calculates the average life and duration of the fixed maturity portfolio two ways:
(a) based on the next call date which is the next call date for callable bonds and the maturity date for noncallable bonds, and
(b) based on the maturity date of all bonds, whether callable or not.
(3) Effective duration is a measure of the price sensitivity of a fixed-income security to a particular change in interest rates.
Credit Risk Sensitivity. The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at December 31, 2022 and 2021.
Fixed Maturities by Sector
December 31, 2022
(Dollar amounts in thousands)
| Corporates: Financial | Below Investment Grade Amortized Cost, net | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Total Fixed Maturities Amortized Cost, net | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | % of Total Fixed Maturities At Amortized Cost, net | At Fair Value |
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance - life, health, P&C | $107,355 | $22 | $(13,966) | $93,411 | $2,375,633 | $44,578 | $(216,938) | $2,203,273 | 13 | 13 |
| Banks | 26,944 | 84 | (192) | 26,836 | 1,336,868 | 14,035 | (100,038) | 1,250,865 | 7 | 8 |
| Other financial | 74,963 | 1 | (22,026) | 52,938 | 1,195,293 | 4,513 | (187,513) | 1,012,293 | 7 | 6 |
| Total financial | 209,262 | 107 | (36,184) | 173,185 | 4,907,794 | 63,126 | (504,489) | 4,466,431 | 27 | 27 |
| Industrial | ||||||||||
| Energy | 44,723 | — | (10,168) | 34,555 | 1,436,598 | 22,637 | (101,923) | 1,357,312 | 8 | 8 |
| Basic materials | — | — | — | — | 1,090,309 | 14,913 | (95,958) | 1,009,264 | 6 | 6 |
| Consumer, non-cyclical | — | — | — | — | 2,146,003 | 20,427 | (232,196) | 1,934,234 | 12 | 12 |
| Other industrials | 25,461 | — | (522) | 24,939 | 1,212,674 | 19,107 | (121,540) | 1,110,241 | 6 | 7 |
| Communications | 28,499 | — | (2,253) | 26,246 | 857,375 | 7,779 | (110,132) | 755,022 | 5 | 5 |
| Transportation | — | — | — | — | 520,029 | 11,684 | (34,269) | 497,444 | 3 | 3 |
| Consumer. cyclical | 149,465 | — | (27,822) | 121,643 | 592,657 | 4,903 | (85,005) | 512,555 | 3 | 3 |
| Technology | — | — | — | — | 247,996 | 90 | (59,672) | 188,414 | 1 | 1 |
| Total industrial | 248,148 | — | (40,765) | 207,383 | 8,103,641 | 101,540 | (840,695) | 7,364,486 | 44 | 45 |
| Utilities | 35,496 | 433 | (3,173) | 32,756 | 1,924,190 | 36,670 | (125,713) | 1,835,147 | 11 | 11 |
| Total corporates | 492,906 | 540 | (80,122) | 413,324 | 14,935,625 | 201,336 | (1,470,897) | 13,666,064 | 82 | 83 |
| States, municipalities, and political divisions: | ||||||||||
| General obligations | — | — | — | — | 915,725 | 5,041 | (167,393) | 753,373 | 5 | 5 |
| Revenues | — | — | — | — | 1,875,305 | 19,287 | (338,054) | 1,556,538 | 10 | 9 |
| Total states, municipalities, and political divisions | — | — | — | — | 2,791,030 | 24,328 | (505,447) | 2,309,911 | 15 | 14 |
| Other fixed maturities: | ||||||||||
| Government (U.S. and foreign) | — | — | — | — | 449,603 | 33 | (51,674) | 397,962 | 2 | 2 |
| Collateralized debt obligations | 37,098 | 13,266 | — | 50,364 | 37,098 | 13,266 | — | 50,364 | — | — |
| Other asset-backed securities | 12,493 | — | (1,618) | 10,875 | 88,336 | 4 | (9,276) | 79,064 | 1 | 1 |
| Total fixed maturities | $542,497 | $13,806 | $(81,740) | $474,563 | $18,301,692 | $238,967 | $(2,037,294) | $16,503,365 | 100 | 100 |
42
Fixed Maturities by Sector
December 31, 2021
(Dollar amounts in thousands)
| Corporates: Financial | Below Investment Grade Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Total Fixed Maturities Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | % of Total Fixed Maturities At Amortized Cost, net | At Fair Value |
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance - life, health, P&C | $57,470 | $3,825 | $(4,807) | $56,488 | $2,345,116 | $513,844 | $(5,553) | $2,853,407 | 13 | 13 |
| Banks | 26,980 | 614 | — | 27,594 | 983,317 | 207,466 | (1,635) | 1,189,148 | 6 | 6 |
| Other financial | 97,800 | 547 | (1,103) | 97,244 | 1,240,340 | 186,431 | (2,161) | 1,424,610 | 7 | 7 |
| Total financial | 182,250 | 4,986 | (5,910) | 181,326 | 4,568,773 | 907,741 | (9,349) | 5,467,165 | 26 | 26 |
| Industrial | ||||||||||
| Energy | 118,538 | 15,941 | (1,445) | 133,034 | 1,587,892 | 346,780 | (1,683) | 1,932,989 | 9 | 9 |
| Basic materials | — | — | — | — | 1,145,222 | 279,175 | (50) | 1,424,347 | 6 | 7 |
| Consumer, non-cyclical | 84,106 | 13,059 | (2,697) | 94,468 | 2,256,802 | 475,012 | (3,397) | 2,728,417 | 13 | 13 |
| Other industrials | 25,565 | 3,182 | — | 28,747 | 1,254,243 | 286,889 | (589) | 1,540,543 | 7 | 7 |
| Communications | 28,699 | 3,002 | — | 31,701 | 876,058 | 153,295 | (3,610) | 1,025,742 | 5 | 5 |
| Transportation | 25,555 | 5,588 | — | 31,143 | 559,399 | 135,581 | (38) | 694,942 | 3 | 3 |
| Consumer. cyclical | 150,624 | 18,805 | (3,429) | 166,000 | 575,597 | 106,438 | (3,594) | 678,441 | 3 | 3 |
| Technology | — | — | — | — | 212,138 | 18,074 | (2,084) | 228,129 | 1 | 1 |
| Total industrial | 433,087 | 59,577 | (7,571) | 485,093 | 8,467,351 | 1,801,244 | (15,045) | 10,253,550 | 47 | 48 |
| Utilities | 36,284 | 3,888 | — | 40,172 | 1,931,391 | 490,119 | (1,012) | 2,420,498 | 11 | 11 |
| Total corporates | 651,621 | 68,451 | (13,481) | 706,591 | 14,967,515 | 3,199,104 | (25,406) | 18,141,213 | 84 | 85 |
| States, municipalities, and political divisions: | ||||||||||
| General obligations | — | — | — | — | 736,853 | 56,163 | (2,060) | 790,956 | 4 | 4 |
| Revenues | — | — | — | — | 1,516,144 | 182,972 | (847) | 1,698,269 | 9 | 8 |
| Total states, municipalities, and political divisions | — | — | — | — | 2,252,997 | 239,135 | (2,907) | 2,489,225 | 13 | 12 |
| Other fixed maturities: | ||||||||||
| Government (U.S., municipal, and foreign) | — | — | — | — | 442,944 | 65,413 | (5,296) | 503,061 | 2 | 2 |
| Collateralized debt obligations | 36,468 | 27,037 | — | 63,505 | 36,468 | 27,037 | — | 63,505 | — | — |
| Other asset-backed securities | 13,457 | — | (414) | 13,043 | 104,998 | 3,715 | (430) | 108,283 | 1 | 1 |
| Total fixed maturities | $701,546 | $95,488 | $(13,895) | $783,139 | $17,804,922 | $3,534,404 | $(34,039) | $21,305,287 | 100 | 100 |
43
Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the December 31, 2022 fixed maturity portfolio, representing 82% of amortized cost, net and 83% of fair value. The remainder of the portfolio is invested primarily in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At December 31, 2022, the total fixed maturity portfolio consisted of 979 issuers.
Fixed maturities had a fair value of $16.5 billion at December 31, 2022, compared with $21.3 billion at December 31, 2021. The net unrealized gain (loss) position in the fixed-maturity portfolio decreased from a $3.5 billion gain position at December 31, 2021 to a loss position of $1.8 billion at December 31, 2022 due to an increase in market rates during the period.
For more information about our fixed maturity portfolio by component at December 31, 2022 and December 31, 2021, including a discussion of allowance for credit losses, an analysis of unrealized investment losses and a schedule of maturities, see Note 4—Investments.
An analysis of the fixed maturity portfolio by a composite quality rating at December 31, 2022 and December 31, 2021, is shown in the following tables. The composite rating for each security, other than private-placement securities managed by third parties, is the average of the security’s ratings as assigned by Moody’s Investor Service, Standard & Poor’s, Fitch Ratings, and Dominion Bond Rating Service, LTD. The ratings assigned by these four nationally recognized statistical rating organizations are evenly weighted when calculating the average. The composite quality rating is created utilizing a methodology developed by Globe Life using ratings from the various rating agencies noted above. The composite quality rating is not a Standard & Poor's credit rating. Standard & Poor's does not sponsor, endorse, or promote the composite quality rating and shall not be liable for any use of the composite quality rating. Included in the following chart are private placement fixed maturity holdings of $466 million at amortized cost, net of allowance for credit losses ($425 million at fair value) for which the ratings were assigned by the third-party managers.
Fixed Maturities by Rating
At December 31, 2022
(Dollar amounts in thousands)
| Amortized Cost, net % of Total Fair Value % of Total Investment grade: | Average Composite Quality Rating on Amortized Cost, net |
|---|---|
| AAA $828,315 5 $733,524 4 | |
| AA 2,779,587 15 2,260,257 14 | |
| A 4,752,633 26 4,438,913 27 | |
| BBB+ 3,934,053 21 3,639,118 22 | |
| BBB 4,254,730 23 3,844,182 23 | |
| BBB- 1,209,877 7 1,112,808 7 | |
| Total investment grade 17,759,195 97 16,028,802 97 | A- |
| Below investment grade: | |
| BB 462,356 3 389,132 3 | |
| B 43,044 — 35,067 — | |
| Below B 37,097 — 50,364 — | |
| Total below investment grade 542,497 3 474,563 3 | BB- |
| $18,301,692 100 $16,503,365 100 | |
| Weighted average composite quality rating | A- |
44
Fixed Maturities by Rating
At December 31, 2021
(Dollar amounts in thousands)
| Amortized Cost % of Total Fair Value % of Total Investment grade: | Average Composite Quality Rating on Amortized Cost |
|---|---|
| AAA $761,526 4 $867,728 4 | |
| AA 2,215,179 13 2,412,947 11 | |
| A 4,487,607 25 5,584,588 26 | |
| BBB+ 3,779,051 21 4,616,977 22 | |
| BBB 4,289,044 24 5,174,667 24 | |
| BBB- 1,570,969 9 1,865,241 9 | |
| Total investment grade 17,103,376 96 20,522,148 96 | A- |
| Below investment grade: | |
| BB 537,064 3 583,608 3 | |
| B 128,402 1 136,026 1 | |
| Below B 36,080 — 63,505 — | |
| Total below investment grade 701,546 4 783,139 4 | BB- |
| $17,804,922 100 $21,305,287 100 | |
| Weighted average composite quality rating | A- |
The overall quality rating of the portfolio is A-, the same as year-end 2021. Fixed maturities rated BBB are 51% of the total portfolio at December 31, 2022 compared with 54% at year-end 2021, and the percentage of BBB bonds to the overall portfolio has been declining since the end of 2018. While this ratio is high relative to our peers, we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of December 31, 2022. Of our fixed maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.
An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:
Below-Investment Grade Fixed Maturities
(Dollar amounts in thousands)
| Year Ended December 31, 2022 | 2021 | |
|---|---|---|
| Balance at beginning of period | $701,546 | $840,739 |
| Downgrades by rating agencies | 50,147 | — |
| Upgrades by rating agencies | (97,462) | (67,078) |
| Dispositions | (116,791) | (78,712) |
| Provision for credit losses | (31) | 2,959 |
| Amortization and other | 5,088 | 3,638 |
| Balance at end of period | $542,497 | $701,546 |
45
Our investment policy calls for investing primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, any increases in below-investment grade issues are typically a result of ratings downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 9% of our shareholders’ equity, excluding the effect of unrealized gains or losses on fixed maturities as of December 31, 2022. Globe Life invests long term and as such, one of our key criterion in our investment process is to select issuers that have the ability to weather multiple financial cycles.
Market Risk Sensitivity. Globe Life's investment securities are exposed to interest rate risk, meaning the effect of changes in financial market interest rates on the current fair value of the Company’s investment portfolio. Since 91% of the carrying value of our investments is attributable to fixed maturity investments and these investments are predominately fixed-rate investments, the portfolio is highly subject to market risk. Declines in market interest rates generally result in the fair value of the investment portfolio rising, and increases in interest rates cause the fair value to decline. Under normal market conditions, we are not concerned about unrealized losses that are interest rate driven since we would not expect to realize them. Globe Life does not generally intend to sell the securities prior to maturity and, likely, will not be required to sell the securities prior to recovery of amortized cost. The long-term nature of our insurance policy liabilities and strong operating cash-flow substantially mitigate any future need to liquidate portions of the portfolio. The increase or decrease in the fair value of insurance liabilities and debt due to increases or decreases in market interest rates largely offsets the impact of rates on the investment portfolio. However, as is permitted by GAAP, these liabilities are not recorded at fair value.
The following table illustrates the interest rate risk sensitivity of our fixed maturity portfolio at December 31, 2022 and 2021. This table measures the effect of a parallel shift in interest rates (as represented by the U.S. Treasury curve) on the fair value of the fixed maturity portfolio. The data measures the change in fair value arising from an immediate and sustained change in interest rates in increments of 100 basis points.
Market Value of Fixed Maturity Portfolio
(Dollar amounts in thousands)
| Change in Interest Rates(1) | At December 31, 2022 | 2021 |
|---|---|---|
| (200) | $20,059,000 | $26,939,000 |
| (100) | 18,177,000 | 23,916,000 |
| 0 | 16,503,000 | 21,305,000 |
| 100 | 15,015,000 | 19,045,000 |
| 200 | 13,690,000 | 17,082,000 |
(1) In basis points.
OPERATING EXPENSES
Operating expenses are included in the "Corporate and Other" segment and are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.
The following table is an analysis of operating expenses for the three years ended December 31, 2022.
Operating Expenses Selected Information
(Dollar amounts in thousands)
| Insurance administrative expenses: | 2022 Amount % of Premium | 2021 Amount % of Premium | 2020 Amount % of Premium |
|---|---|---|---|
| Salaries | $129,711 3.0 | $115,852 2.8 | $105,935 2.8 |
| Other employee costs | 42,319 1.0 | 41,841 1.0 | 39,885 1.0 |
| Information technology costs | 55,526 1.3 | 47,923 1.2 | 45,742 1.2 |
| Legal costs | 12,056 0.3 | 15,494 0.4 | 11,256 0.3 |
| Other administrative costs | 59,729 1.4 | 50,521 1.2 | 48,129 1.3 |
| Total insurance administrative expenses | 299,341 7.0 | 271,631 6.6 | 250,947 6.6 |
| Parent company expense | 11,156 | 9,553 | 9,891 |
| Stock compensation expense | 35,650 | 30,272 | 35,892 |
| Legal proceedings | 2,496 | 8,139 | 3,275 |
| Non-operating expenses | 5,311 | 2,434 | 1,033 |
| Total operating expenses, per Consolidated Statements of Operations | $353,954 | $322,029 | $301,038 |
| 2022 | 2021 | 2020 | |
| Amount% | Amount% | Amount% | |
| Total insurance administrative expenses increase (decrease) over prior year | $27,710 10.2 | $20,684 8.2 | $10,626 4.4 |
| Total operating expenses increase (decrease) over prior year | 31,925 9.9 | 20,991 7.0 | (3,787) (1.2) |
Total operating expenses 2022 increased 10% over the prior year reflecting higher insurance administrative expenses. Insurance administrative expenses increased $28 million primarily due to higher information technology costs, including associated information technology salaries, higher employee costs in general, and higher administrative costs associated with the acquisition of Globe Life Benefits, which occurred in late 2021. Insurance administrative expenses as a percent of premium were 7.0%, compared to 6.6% for the same period in 2021.
SHARE REPURCHASES
Globe Life has an ongoing share repurchase program that began in 1986, and is reviewed with the Board of Directors by management quarterly and annually reaffirmed by the Board of Directors. With no specified authorization amount, we determine the amount of repurchases based on the amount of the excess cash flows after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance subsidiaries less interest expense paid on its debt and other limited operating activities. The majority of our share repurchases are made from excess cash flow after the payment of shareholder dividends. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises. On August 10, 2022, the Board of Directors reauthorized the Parent Company’s share repurchase program in amounts and with timing that management, in consultation with the Board, determines to be in the best interest of the Company and its shareholders.
The following table summarizes share purchase activity for each of the last three years.
Analysis of Share Purchases
(Amounts in thousands)
| Purchases with: | 2022 Shares | Amount | 2021 Shares | Amount | 2020 Shares | Amount |
|---|---|---|---|---|---|---|
| Share repurchase program | 3,322 | $335,145 | 4,784 | $455,030 | 4,459 | $380,112 |
| Option proceeds | 1,103 | 119,493 | 858 | 86,405 | 676 | 63,754 |
| Total | 4,425 | $454,638 | 5,642 | $541,435 | 5,135 | $443,866 |
Throughout the remainder of this discussion, share purchases refer only to those made from excess cash flow at the Parent Company.
FINANCIAL CONDITION
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper and the Federal Home Loan Bank.
Insurance Subsidiary Liquidity. The operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of the excess cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’ operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the leading source of the excess cash is investment income, a significant portion of the excess cash also comes from underwriting income due to our high underwriting margins and effective expense control. While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed maturity investment portfolio available to create additional cash flows if required.
Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries with an additional source of liquidity, if needed. Refer to Note 11—Debt for further details.
Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
(Amounts in Thousands)
| Liquidity Sources: | Year Ended December 31, Projected 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Dividends from Subsidiaries | $465,000 | $407,042 | $478,535 | $485,871 |
| Excess Cash Flows | 345,000 | 278,434 | 370,120 | 387,606 |
For more information on the restrictions on the payment of dividends by subsidiaries, see the Restrictions section of Note 12—Shareholders' Equity. Although these restrictions exist, dividend availability from subsidiaries historically has been more than sufficient for the cash flow needs of the Parent Company.
Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany borrowings, public debt markets, term loans, and a revolving credit facility. At December 31, 2022, the Parent Company had access to $91 million of invested cash, net intercompany receivables, and other liquid assets. The credit facility is discussed below.
Short-Term Borrowings. An additional source of Parent Company liquidity is a revolving credit facility with a group of lenders which allows unsecured borrowings and stand-by letters of credit up to $750 million, which could be extended up to $1 billion. While Globe Life can request the extension, it is not guaranteed. Up to $250 million in letters of credit can be issued against the facility. The facility is further designated as a back-up line of credit for a commercial paper program under which commercial paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum less any letters of credit issued. As of December 31, 2022, we had available $340 million of additional borrowing capacity under this facility, compared with $295 million a year earlier. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. Globe Life has consistently been able to issue commercial paper as needed during the three years ended December 31, 2022. As discussed in Note 11—Debt, on September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020. The five-year credit agreement will now mature on September 30, 2026. As of December 31, 2022, the Parent Company was in full compliance with all covenants related to the aforementioned debt.
As a part of the credit facility, Globe Life has stand-by letters of credits. These letters are issued among our subsidiaries, one of which is an offshore captive reinsurer, and have no impact on company obligations as a whole. Any future regulatory changes that restrict the use of off-shore captive reinsurers might require Globe Life to obtain third-party financing, which could cause an insignificant increase in financing costs. On October 26, 2021, the letters of credit were amended to reduce the amount outstanding from $135 million to $125 million. The outstanding letters of credit remained at $125 million at December 31, 2022.
The Parent Company expects to have readily available funds for 2023 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through internally generated cash flow and the credit facility. In the unlikely event that more liquidity is needed, the Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility, and intercompany borrowing. Refer to Note 6—Commitments and Contingencies and the discussion surrounding the Company's obligations over the next five years.
As noted above, the Parent Company had access to $91 million of liquid assets available as of December 31, 2022. This liquidity is available to the Company in the event additional funds are needed to support the targeted capital levels within our insurance subsidiaries.
Consolidated Liquidity. Consolidated net cash inflows provided from operations were $1.42 billion in 2022, compared with $1.44 billion in 2021. In addition to cash inflows from operations, our companies received proceeds from maturities, calls, and repayments of fixed maturities in the amount of $462 million in 2022, compared with $311 million in 2021. As noted under the caption Credit Facility in Note 11, the Parent Company has in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.
Cash and short-term investments were $207 million at the end of 2022 compared with $161 million at the end of 2021. In addition to these liquid assets, the entire $16.5 billion (fair value at December 31, 2022) portfolio of fixed income securities is available for sale in the event of an unexpected need. Approximately 97% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. We generally expect to hold fixed income securities to maturity, and even though these securities are classified as available for sale, we have the ability and general intent to hold any securities until recovery or maturity. Our strong cash flows from operations, ongoing investment maturities, and credit line availability make any need to sell securities for liquidity highly unlikely.
Capital Resources. The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt), long-term debt, and shareholders’ equity.
Debt: The carrying value of the long-term debt was $1.6 billion at December 31, 2022, an increase from $1.5 billion a year earlier. A complete analysis and description of long-term debt issues outstanding is presented in Note 11—Debt.
Subsidiary Capital: The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of risk-based capital determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC). Companies typically hold a multiple of the Company Action Level RBC depending on their particular business needs and risk profile.
Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2022, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company concludes that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. As of December 31, 2022, our consolidated Company Action Level RBC ratio was 321%, compared to 315% in the prior year. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.
In August 2022, the NAIC fully adopted new and expanded C-2 life insurance mortality risk factors. The adoption of these factors resulted in higher amounts of required capital related to our life insurance liabilities. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.
Shareholder's Equity: As noted under the caption Analysis of Share Purchases within this report, we have an ongoing share repurchase program.
Globe Life has continually increased the quarterly dividend on its common shares over the past three years.
| Year Ended December 31, Projected 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Quarterly dividend by annual year | $0.2250 | $0.2075 | $0.1975 | $0.1875 |
Shareholders’ equity was $4.9 billion at December 31, 2022, compared with $8.6 billion at December 31, 2021, a decrease of $3.7 billion or 43%. Since December 31, 2021, shareholders’ equity was reduced by $4.2 billion due to after-tax unrealized losses in the fixed-maturity portfolio as interest rates increased over the period offset by $740 million of net income during this period. In addition, shareholders' equity was reduced by $335 million in share purchases under the repurchase program and an additional $119 million in share purchases to offset the dilution from stock option exercises.
We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Excess cash flow, as we define it, results primarily from the dividends received by the Parent Company from its subsidiaries less the interest paid on debt. The cash received by the Parent Company from our insurance subsidiaries is after they have made substantial investments during the year to grow the business. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, increases in shareholder dividends, investment in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.
As discussed in Note 1—Significant Accounting Policies, the Company will adopt ASU 2018-12, Financial Services–Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI), effective on January 1, 2023. The accounting adoption will have no economic impact on the cash flows of our business nor influence our business model of providing basic protection oriented products to the underserved and low to middle-income market. In addition, the adoption will not impact our capital management philosophies. It will, however, modify the timing of when profits emerge on our insurance policies. We are anticipating GAAP net income and net operating income to increase under the new standard primarily due to the significant reduction in DAC amortization in the near or intermediate term. With respect to equity, we anticipate a significant decrease as a result of the requirement to use current discount rates to remeasure the policy liabilities and record the offset through AOCI at adoption. Since current rates (upper-medium grade) are lower than the locked-in rates assumed in valuing our policy liabilities, we will have unrealized interest rate loss recognized through AOCI.
We maintain a significant available-for-sale fixed maturity portfolio to support our insurance policy liabilities. Current accounting guidance requires that we revalue our portfolio to fair market value at the end of each accounting period. The period-to-period changes in fair value, net of their associated impact on deferred acquisition costs and income tax, are reflected directly in shareholders’ equity. Changes in the fair value of the portfolio can result from changes in market rates.
While a majority of invested assets are revalued, accounting rules do not permit interest-bearing insurance policy liabilities to be valued at fair value in a consistent manner as that of assets, with changes in value applied directly to shareholders’ equity. Due to the size of our policy liabilities in relation to our shareholders’ equity, an inconsistency exists in measurement, which may have a material impact on the reported value of shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed maturities and liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the general intent and ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit rating agencies, lenders, many industry analysts, and certain other financial statement users prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
The following table presents selected data related to our capital resources. Additionally, the table presents the effect of this accounting guidance on relevant line items, so that investors and other financial statement users may determine its impact on Globe Life's capital structure. Excluding the effect of unrealized gains or losses on the fixed maturity portfolio from shareholders' equity is considered non-GAAP. Below we include the reconciliation to GAAP.
Selected Financial Data
(Dollar amounts in thousands, except per share data)
| At December 31, 2022 GAAP | Effect of Accounting Rule Requiring Revaluation(1) | December 31, 2021 GAAP | Effect of Accounting Rule Requiring Revaluation(1) | December 31, 2020 GAAP | Effect of Accounting Rule Requiring Revaluation(1) | |
|---|---|---|---|---|---|---|
| Fixed maturities | $16,503,365 | $(1,798,327) | $21,305,287 | $3,500,365 | $21,213,509 | $4,019,710 |
| Deferred acquisition costs(2) | 5,249,907 | 5,380 | 4,914,728 | (4,327) | 4,595,444 | (5,955) |
| Total assets | 25,537,159 | (1,792,947) | 29,768,048 | 3,496,038 | 29,046,731 | 4,013,755 |
| Short-term debt | 449,103 | — | 479,644 | — | 254,918 | — |
| Long-term debt | 1,627,952 | — | 1,546,494 | — | 1,667,886 | — |
| Shareholders' equity | 4,895,861 | (1,416,428) | 8,642,806 | 2,761,870 | 8,771,092 | 3,170,866 |
| Book value per diluted share | 49.65 | (14.36) | 85.97 | 27.47 | 83.19 | 30.07 |
| Debt to capitalization(3) | 29.8% | 5.0% | 19.0% | (6.6)% | 18.0% | (7.6)% |
| Diluted shares outstanding | 98,615 | 100,535 | 105,429 | |||
| Actual shares outstanding | 96,740 | 99,567 | 103,797 |
(1) Amount added to (deducted from) comprehensive income to produce the stated GAAP item, per accounting rule ASC 320-10-35-1.
(2) Includes the value of business acquired (VOBA).
(3) Globe Life's debt covenants require that the effect of this accounting rule be removed to determine this ratio. This ratio is computed by dividing total debt by the sum of total debt and shareholders’ equity.
Financial Strength Ratings. The financial strength of our major insurance subsidiaries is rated by Standard & Poor’s and A. M. Best. The following table presents these ratings for our five largest insurance subsidiaries at December 31, 2022.
| Standard & Poor’s | A.M. Best | |
|---|---|---|
| Liberty National Life Insurance Company | AA- | A |
| Globe Life And Accident Insurance Company | AA- | A |
| United American Insurance Company | AA- | A |
| American Income Life Insurance Company | AA- | A |
| Family Heritage Life Insurance Company of America | NR | A |
A.M. Best states that it assigns an A (Excellent) rating to insurance companies that have, in its opinion, an excellent ability to meet their ongoing insurance obligations.
The AA financial strength rating category is assigned by Standard & Poor’s Corporation (S&P) to those insurers which have very strong capacity to meet its financial commitments which differs from the highest-rated insurers only to a small degree. An insurer rated A has strong capacity to meet its financial commitments but it is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than insurers in higher-rated categories. The plus sign (+) or minus sign (-) shows the relative standing within the major rating category.
OTHER ITEMS
Litigation. For more information concerning litigation, please refer to Note 6—Commitments and Contingencies.
CRITICAL ACCOUNTING POLICIES
Application of Critical Accounting Estimates. The preparation of financial statements in conformity with GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management reviews these key estimates and assumptions used in the preparation of financial statements on a timely basis. If management determines that modifications are necessary due to current facts and circumstances, the Company’s results of operations and financial position as reported in the consolidated financial statements could possibly change significantly.
The following accounting policies are deemed critical to the preparation of the financial statements and include accounting estimates that management believes are most subjective or have complex judgments.
Future Policy Benefits. Due to the long-term nature of insurance contracts, our insurance companies are liable for policy benefit payments that will be made in the future. The liability for future policy benefits is determined by standard actuarial procedures common to the life insurance industry. The accounting policies for determining this liability are disclosed in Note 1—Significant Accounting Policies.
Approximately 90% of our liabilities for future policy benefits at December 31, 2022 were traditional insurance liabilities where the liability is determined as the present value of future benefits less the present value of the portion of the gross premium required to pay for such benefits. The assumptions used in estimating the future benefits for this portion of business are set at the time of contract issue. These assumptions are “locked in” and are not revised for the lifetime of the contracts, except where there is a premium deficiency, as defined in Note 1—Significant Accounting Policies under the caption Future Policy Benefits. Otherwise, variability in the accrual of policy reserve liabilities after policy issuance is caused only by variability of the inventory of in force policies.
The remaining portion of liabilities for future policy benefits pertains to business accounted for as deposit business, where the recorded liability is the fund balance attributable to the benefit of policyholders as determined by the policy contract at the consolidated financial statement date. Accordingly, there are no assumptions used to determine the future policy benefit liability for deposit business.
Refer to Note 1—Significant Accounting Policies for discussion on the significant changes to future policy benefits with an effective date of January 1, 2023.
Deferred Acquisition Costs. Certain costs of acquiring new business are deferred and recorded as an asset. Deferred acquisition costs consist primarily of sales commissions and other underwriting costs such as advertising related to the successful issuance of a new insurance contract as indicated in Note 1—Significant Accounting Policies under the caption Deferred Acquisition Costs in the Notes to Consolidated Financial Statements. Additionally, the cost of acquiring blocks of insurance business or insurance business through the purchase of other companies, known as the value of insurance acquired (VOBA), is included in deferred acquisition costs. Our policies for accounting for deferred acquisition costs and the associated amortization are reported under the same caption in Note 1—Significant Accounting Policies.
Over 99% of our deferred acquisition costs at December 31, 2022 were related to traditional products and are being amortized over the premium-paying period in proportion to the present value of actual historic and estimated future gross premiums. The projection assumptions for this business are set at the time of contract issue. These assumptions are “locked-in” at that time and, except where there is a loss recognition issue, are not revised for the lifetime of the contracts. Absent a premium deficiency, variability in amortization after policy issuance is caused only by variability in premium volume. We have not recorded a deferred acquisition cost loss recognition event for assets related to this business for any period in the three years ended December 31, 2022.
Less than 1% of deferred acquisition costs pertain to deposit business for which deferred acquisition costs are amortized over the estimated lives of the contracts.
Policy Claims and Other Benefits Payable. This liability consists of known benefits currently payable and an estimate of claims that have been incurred but not yet reported to us. The estimate of unreported claims is based on prior experience and is made after careful evaluation of all information available to us. However, the factors upon which these estimates are based can be subject to change from historical patterns. Factors involved include the litigation environment, regulatory mandates, and the introduction of policy types for which claim patterns are not well established, and medical trend rates and medical cost inflation as they affect our health claims. Changes in these estimates, if any, are reflected in the earnings of the period in which the adjustment is made. The Company concludes that the estimates used to produce the liability for claims and other benefits, including the estimate of unsubmitted claims, are the most appropriate under the circumstances. However, there is no certainty that the resulting stated liability will be our ultimate obligation. At this time, we do not expect any change in this estimate to have a material impact on earnings or financial position consistent with our historical experience. There were no significant changes in the claims process in the current year.
Valuation of Fixed Maturities. We hold a substantial investment in high-quality fixed maturities to provide for the funding of our future policy contractual obligations over long periods of time. While these securities are generally expected to be held to maturity, they are classified as available for sale and are sold from time to time to maximize risk-adjusted, capital-adjusted returns. We report this portfolio at fair value. Fair value is the price that we would expect to receive upon sale of the asset in an orderly transaction. The fair value of the fixed maturity portfolio is primarily affected by changes in interest rates in financial markets. Because of the size of our fixed maturity portfolio and the long average life, small changes in rates can have a significant effect on the portfolio and the reported financial position of the Company. This impact is disclosed in 100 basis point increments under the caption Market Risk Sensitivity in this report. However, as discussed under the caption Financial Condition in this report, the Company regards these unrealized fluctuations in value as having no meaningful impact on our actual financial condition and, as such, we remove them from consideration when viewing our financial position and financial ratios.
At times, the values of our fixed maturities can also be affected by illiquidity in the financial markets. Illiquidity would contribute to a spread widening, and accordingly to unrealized losses, on many securities that we would expect to be fully recoverable. Even though our fixed maturity portfolio is available for sale, we have the ability and general intent to hold the securities until maturity as a result of our strong and stable cash flows generated from our insurance products. Considerable information concerning the policies, procedures, classification levels, and other relevant data concerning the valuation of our fixed maturity investments is presented in Note 1—Significant Accounting Policies and in Note 4—Investments under the captions Fair Value Measurements in both notes. There were no significant changes in the valuation process in the current year.
Investments: Allowance for Credit Losses. We continually monitor our investment portfolio for investments where fair value has declined below carrying value to determine if a credit loss event has occurred. When a credit event does occur, an allowance for credit loss is recorded and the corresponding provision is recognized in the Consolidated Statements of Operations in Realized Gains or Losses. Non-credit related fluctuations in the fair value are recorded in Other Comprehensive Income. The policies and procedures that we use to evaluate and account for allowance for credit losses are disclosed in Note 1—Significant Accounting Policies and the discussions under the captions Investments and Realized Gains and Losses in this report. While every effort is made to make the best estimate of status and value with the information available regarding an allowance for credit loss, it is difficult to predict the future prospects of a distressed or impaired security.
Defined benefit pension plans. We maintain funded defined benefit plans covering most full-time employees. We also have an unfunded nonqualified defined benefit plan covering a limited number of officers. Our obligations under these plans are determined actuarially based on specified actuarial assumptions. In accordance with GAAP, an expense is recorded each year as these pension obligations grow due to the increase in the service period of employees and the interest cost associated with the passage of time. These obligations are offset, at least in part, by the growth in value of the assets in the funded plans. At December 31, 2022, our gross liability under these plans was $563 million, but was offset by assets of $500 million.
The actuarial assumptions used in determining our obligations/expenses for pensions include: employee mortality and turnover, retirement age, the expected return on plan assets, projected salary increases, and the discount rate at which future obligations could be settled. Additionally, a corridor approach is used to amortize any unrecognized gains or losses outside the corridor (the standard 10% of the greater of plan PBO and fair value assets) and have an amortization service period of approximately nine years. These assumptions have an important effect on the pension obligation. A decrease in the discount rate will cause an increase in the pension obligation. A decrease in projected salary increases will cause a decrease in this obligation. Small changes in assumptions may cause significant differences in reported results for these plans. For example, a sensitivity analysis is presented below for the impact of change in the discount rate and the long-term rate of return on assets assumed on our defined benefit pension plans expense for the year 2022 and projected benefit obligation as of December 31, 2022.
Pension Assumptions
(Dollar amounts in thousands)
| Assumption Discount Rate(2): | Change(1) | Impact on Expense | Impact on Projected Benefit Obligation |
|---|---|---|---|
| Increase | 25 | $(2,020) | $(18,163) |
| Decrease | (25) | 882 | 19,148 |
| Expected Return(3): | |||
| Increase | 25 | (1,381) | — |
| Decrease | (25) | 1,381 | — |
(1) In basis points.
(2) The discount rate for determining the net periodic benefit cost was 3.19% for 2022. The discount rate used for determining the projected benefit obligation as of December 31, 2022 was 5.71%.
(3) The expected long-term return rate assumed was 6.98% at December 31, 2022, and 6.67% in the prior year. Management considers both historical and future yields to determine the expected return.
The Company determines mortality assumptions through the use of published mortality tables that reflect broad-based studies of mortality and published longevity improvement scales.
The criteria used to determine the primary assumptions are discussed in Note 9—Postretirement Benefits. While we have used our best efforts to determine the most reliable assumptions, given the information available from Company experience, economic data, independent consultants and other sources, we cannot be certain that actual results will be the same as expected. The assumptions are reviewed annually and revised, if necessary, based on more current information available to us. Note 9—Postretirement Benefits also contains information about pension plan assets, investment policies, and other related data. There were no significant changes in the assumptions in the current year.
Controls and procedures
As filed, 9,008 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures: Globe Life, under the direction of the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
As of the end of the fiscal year completed December 31, 2022, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Chief Executive Officers and the Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-K. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-K.
Management's Annual Report on Internal Control over Financial Reporting: Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Management evaluated the design and operating effectiveness of the Company's internal control over financial reporting based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission. Based upon their evaluation as of December 31, 2022, the Chief Executive Officers, and the Executive Vice President and Chief Financial Officer have concluded that Globe Life's internal control over financial reporting is effective as of the date of this Form 10-K. In compliance with Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-K.
Changes in Internal Control over Financial Reporting: As of the period ended December 31, 2022, there have not been any changes in Globe Life Inc.'s internal control over financial reporting or in other factors that could significantly affect this control over financial reporting subsequent to the date of their evaluation which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
Refer to Deloitte & Touche LLP's, independent registered public accounting firm, attestation report on the Company's internal controls over financial reporting.
MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management at Globe Life is responsible for establishing and maintaining adequate internal control over financial reporting for the Company and for assessing the effectiveness of internal control on an annual basis. As a framework for assessing internal control over financial reporting, the Company utilizes the criteria for effective internal control over financial reporting described in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
There are inherent limitations in the effectiveness of any internal control, including the possibility of human error and the circumvention or overriding of controls. Accordingly, even effective internal controls can provide only reasonable assurance with respect to financial statement preparation. Further, because of changes in conditions, the effectiveness of internal control may vary over time.
Management evaluated the Company’s internal control over financial reporting, and based on its assessment, determined that the Company’s internal control over financial reporting was effective as of December 31, 2022. The Company’s independent registered public accounting firm has issued an attestation report on the Company’s internal control over financial reporting as stated in their report which is included herein.
/s/ J. Matthew Darden
J. Matthew Darden Co-Chief Executive Officer
/s/ Frank M. Svoboda
Frank M. Svoboda Co-Chief Executive Officer
/s/ Thomas P. Kalmbach
Thomas P. Kalmbach Executive Vice President and Chief Financial Officer
February 22, 2023
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of Globe Life Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Globe Life Inc. and subsidiaries (the “Company”) as of December 31, 2022, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements and financial statement schedules as of and for the year ended December 31, 2022 of the Company and our report dated February 22, 2023, expressed an unqualified opinion on those financial statements and financial statement schedules.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ DELOITTE & TOUCHE LLP
Dallas, Texas
February 22, 2023
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $5.21bn | us-gaap:Revenues |
| Gross profit | 12 months2022-01-01 to 2022-12-31 | $982.9m | us-gaap:GrossProfit |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $990.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $90.4m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $166.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $739.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $7.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $7.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 98,984,644 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $1.42bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $27.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $80.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $454.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $92.6m | us-gaap:Cash |
| Total assets | At period end2022-12-31 | $25.54bn | us-gaap:Assets |
| Total liabilities | At period end2022-12-31 | $20.64bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $1.63bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-12-31 | $165.5m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2022-12-31 | $449.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-12-31 | $4.90bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000320335-23-000008. Last ingested by Listed: Nov 14, 2026, 12:51 ET. Listed shows no prices and gives no investment advice.